54 results on '"Gallo MP"'
Search Results
2. presenza e funzionalità dei canali del calcio di tipo L in cellule staminali mesenchimali in cocultura con cardiomiociti adulti
- Author
-
Gallo, Mp, GALLO ROSSO, A, Penna, Claudia, Alloatti, Giuseppe, Pagliaro, Pasquale, Losano, Giovanni, and Levi, Renzo
- Published
- 2005
3. Differential effects of paclitaxel and derivatives on guinea pig isolated heart and papillary muscle
- Author
-
Alloatti, G., Penna, C., Gallo, Mp, Levi, Rc, Bombardelli, E., and Giovanni Battista APPENDINO
- Subjects
Paclitaxel ,Guinea Pigs ,Action Potentials ,Arrhythmias, Cardiac ,Heart ,Docetaxel ,In Vitro Techniques ,Papillary Muscles ,Membrane Potentials ,Vasodilation ,Heart Rate ,Coronary Circulation ,Animals ,Taxoids - Abstract
Paclitaxel (Taxol) is an anticancer agent with clinical activity against various human cancer types. Paclitaxel blocks cell division by stabilizing microtubules, a mechanism that also underlies its major side effects (neutropenia and neurotoxicity). Paclitaxel can also alter cardiac function, and to elucidate the mechanism of this activity, we tested the mechanical and electrical effects of paclitaxel and a series of analogs (docetaxel, taxol B, taxol C and N-methyltaxol C; 5-20 microM) on two different cardiac preparations, the isolated coronary perfused heart and the papillary muscle of the guinea pig. Paclitaxel and N-methyltaxol C induced conduction arrhythmias and reduced coronary flow and left ventricular systolic pressure in the isolated heart, whereas the other taxol derivatives tested had no significant effect. Moreover, paclitaxel blocked the vasodilator effect of bradykinin in the isolated heart. Paclitaxel and N-methyltaxol C produced a positive inotropic effect in papillary muscle, without alterations in the action potential. In the latter preparation, no significant variations were observed after treatment with the other taxol derivatives. The in vitro cardiodepressant and arrhythmogenic activity of paclitaxel is similar to that reported after its clinical administration and might be due to coronary vasoconstriction. The precise role of microtubules as modulators of intracellular calcium in cardiac and smooth muscle cells is at present unclear, because docetaxel and other taxol analogs, though they exhibited similar activity on tubulin, lacked cardiac effects.
- Published
- 1998
4. Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes
- Author
-
Francesca Bonafè, Pasquale Pagliaro, Andrea Marcantoni, Claudia Penna, Giuseppe Alloatti, Gianni Losano, Maria Pia Gallo, Renzo Levi, Roberta Ramella, Gallo MP, Ramella R, Alloatti G, Penna C, Pagliaro P, Marcantoni A, Bonafé F, Losano G, and Levi R
- Subjects
Boron Compounds ,Sarcomeres ,Dihydropyridines ,Nifedipine ,Cellular differentiation ,Green Fluorescent Proteins ,sarcomeric proteins ,chemistry.chemical_element ,cardiomyocytes ,Myosins ,Biology ,Calcium ,Biochemistry ,Calcium in biology ,Animals, Genetically Modified ,mesenchymal stem cells ,calcium channels ,cardiomyocytes, mesenchymal stem cells, calcium channels, sarcomeric proteins ,Animals ,Myocyte ,Actinin ,Myocytes, Cardiac ,Molecular Biology ,Cells, Cultured ,Fluorescent Dyes ,Calcium signaling ,Calcium metabolism ,Voltage-dependent calcium channel ,Mesenchymal stem cell ,Cell Differentiation ,Cell Biology ,Calcium Channel Blockers ,Coculture Techniques ,Rats ,Cell biology ,chemistry ,Connexin 43 ,Ion Channel Gating - Abstract
In order to assess, in a controlled in vitro model, the differentiation potential of adult bone marrow derived stem cells we have developed a coculture procedure using adult rat cardiomyocytes and mesenchymal stem cells (MSCs) from transgenic GFP positive rats. We investigated in the cocultured MSCs the time course of cellular processes that are difficult to monitor in in vivo experiments. Adult rat cardiomyocytes and adult rat MSCs were cocultured for up to 7 days and analyzed by confocal microscopy. Several markers were studied by immunofluorescence technique. The fluorescent ST-BODIPY-Dihydropyridine was used to label calcium channels in living cells. Intracellular calcium was monitored with the fluorescent probe X-Rhod-1. Immunofluorescence experiments showed the presence of connexin-43 between cardiomyocytes and MSCs and between MSCs, while no sarcomeric structures were observed at any time of the coculture. We looked at the expression of calcium channels and development of voltage-dependent calcium signaling in cocultured MSCs. MSCs showed a time-dependent increase of labeling of ST-BODIPY-Dihydropyridine, reaching a relatively strong level after 72 h of coculture. The treatment with a non-fluorescent DHP, Nifedipine, completely abolished ST-BODIPY labeling. We investigated whether depolarization could modulate intracellular calcium. Depolarization-induced calcium transients increased in MSCs in relation to the coculture time. We conclude that MSCs cocultured with adult cardiomyocytes present preliminary evidence of voltage-dependent calcium modulation uncoupled with the development of nascent or adult myofibrils, thus showing a limited lineage specification and a low plasticity to differentiate in a full cardiomyocyte-like phenotype.
- Published
- 2007
5. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
- Author
-
Pasquale Pagliaro, Giuseppe Alloatti, Claudia Penna, Carlo G. Tocchetti, Maria Pia Gallo, Riccarda Granata, Penna, C, Granata, R, Tocchetti, CARLO GABRIELE, Gallo, Mp, Alloatti, G, and Pagliaro, P.
- Subjects
Cardiotonic Agents ,Clinical Biochemistry ,Myocardial Ischemia ,Ischemia ,Myocardial Reperfusion Injury ,Endogeny ,Pharmacology ,Nitric Oxide ,Nitric oxide ,chemistry.chemical_compound ,Drug Discovery ,Animals ,Humans ,Medicine ,Cardioprotective Agent ,Hydrogen Sulfide ,Myocardial infarction ,Ischemic Postconditioning ,Cardioprotection ,Carbon Monoxide ,Gasotransmitters ,business.industry ,medicine.disease ,chemistry ,Anesthesia ,Ischemic Preconditioning, Myocardial ,Molecular Medicine ,Ischemic preconditioning ,business ,Reperfusion injury - Abstract
Cardiovascular diseases (CVD) are the leading cause of death, chronic illness and disability in Western countries. The most common cause of CVD derives from the harmful effects of acute myocardial ischemia and subsequent reperfusion injury. Cardioprotection against acute ischemia/ reperfusion injury is made possible by the "conditioning protocols." Conditioning is obtained by applying a few periods of brief ischemia and reperfusion in the event of prolonged (index) ischemia that may cause myocardial infarction. Whilst the conditioning stimulus is applied before the index ischemia in ischemic pre-conditioning, it is applied after the event in post-conditioning. Pre and post- conditioning stimuli can be applied in a different/remote organ (remote pre- and post-conditioning); in this case conditioning stimulus can also be applied during the index event, in the so called remote per-conditioning. All these endogenous cardioprotective strategies recruit endogenous cytoprotective agents and factors that elicit specific cardioprotective pathways. Here, we discuss many of these cardioprotective factors compared to literature and highlight their main characteristics and mechanisms of action. Enphasis is given to endogenous cardioprotective agents acting or not on surface receptors, including chromogranin A derivatives, ghrelin-associated peptides, growth factors and cytokines, and to microvesicles and exosomes. Moreover the cardioprotective effects of gasotransmitters nitric oxide, hydrogen sulphide and carbon monoxide are reviewed. The possible clinical translation of these knowledge for future successful therapies is briefly and critically discussed.
6. Insulin-Activated Signaling Pathway and GLUT4 Membrane Translocation in hiPSC-Derived Cardiomyocytes.
- Author
-
Querio G, Antoniotti S, Levi R, Fleischmann BK, Gallo MP, and Malan D
- Subjects
- Humans, Phosphorylation, Cell Differentiation, GTPase-Activating Proteins metabolism, Cell Line, Glucose Transporter Type 4 metabolism, Myocytes, Cardiac metabolism, Induced Pluripotent Stem Cells metabolism, Induced Pluripotent Stem Cells cytology, Insulin metabolism, Insulin pharmacology, Signal Transduction, Cell Membrane metabolism, Protein Transport, Proto-Oncogene Proteins c-akt metabolism
- Abstract
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are a cell model now widely used to investigate pathophysiological features of cardiac tissue. Given the invaluable contribution hiPSC-CM could make for studies on cardio-metabolic disorders by defining a postnatal metabolic phenotype, our work herein focused on monitoring the insulin response in CM derived from the hiPSC line UKBi015-B. Western blot analysis on total cell lysates obtained from hiPSC-CM showed increased phosphorylation of both AKT and AS160 following insulin treatment, but failed to highlight any changes in the expression dynamics of the glucose transporter GLUT4. By contrast, the Western blot analysis of membrane fractions, rather than total lysates, revealed insulin-induced plasma membrane translocation of GLUT4, which is known to also occur in postnatal CM. Thus, these findings suggest that hiPSC-derived CMs exhibit an insulin response reminiscent to that of adult CMs regarding intracellular signaling and GLUT4 translocation to the plasma membrane, representing a suitable cellular model in the cardio-metabolic research field. Moreover, our studies also demonstrate the relevance of analyzing membrane fractions rather than total lysates in order to monitor GLUT4 dynamics in response to metabolic regulators in hiPSC-CMs.
- Published
- 2024
- Full Text
- View/download PDF
7. Indole-3-Propionic Acid, a Gut Microbiota-Derived Tryptophan Metabolite, Promotes Endothelial Dysfunction Impairing Purinergic-Induced Nitric Oxide Release in Endothelial Cells.
- Author
-
Geddo F, Antoniotti S, Gallo MP, and Querio G
- Subjects
- Animals, Cattle, Endothelial Cells metabolism, Nitric Oxide metabolism, Tryptophan metabolism, Nitric Oxide Synthase Type III metabolism, Indoles pharmacology, Indoles metabolism, Gastrointestinal Microbiome, Vascular Diseases metabolism, Propionates
- Abstract
Different gut microbiota-derived metabolites influence cardiovascular function, and, among all, the role of indole-3-propionic acid (IPA), from tryptophan metabolism, shows controversial effects. The aim of this study was to evaluate its role in endothelial dysfunction. IPA effects were studied on bovine aortic endothelial cells (BAE-1). First, IPA cytotoxicity was evaluated by an MTS assay. Then, the levels of intracellular reactive oxygen species (ROS) were evaluated by a microplate reader or fluorescence microscopy with the CellROX
® Green probe, and nitric oxide (NO) production was studied by fluorescence microscopy with the DAR4M-AM probe after acute or chronic treatment. Finally, immunoblotting analysis for endothelial nitric oxide synthase (eNOS) phosphorylation (p-eNOS) was performed. In BAE-1, IPA was not cytotoxic, except for the highest concentration (5 mM) after 48 h of treatment, and it showed neither oxidant nor antioxidant activity. However, the physiological concentration of IPA (1 μM) significantly reduced NO released by adenosine triphosphate (ATP)-stimulated BAE-1. These last data were confirmed by Western blot analysis, where IPA induced a significant reduction in p-eNOS in purinergic-stimulated BAE-1. Given these data, we can speculate that IPA negatively affects the physiological control of vascular tone by impairing the endothelial NO release induced by purinergic stimulation. These results represent a starting point for understanding the mechanisms underlying the relationship between gut microbiota metabolites and cardiometabolic health.- Published
- 2024
- Full Text
- View/download PDF
8. Improving endothelial health with food-derived H 2 S donors: an in vitro study with S -allyl cysteine and with a black-garlic extract enriched in sulfur-containing compounds.
- Author
-
Geddo F, Querio G, Asteggiano A, Antoniotti S, Porcu A, Occhipinti A, Medana C, and Gallo MP
- Subjects
- Animals, Cattle, Antioxidants pharmacology, Antioxidants metabolism, Sulfur Compounds pharmacology, Endothelial Cells metabolism, Cysteine pharmacology, Endothelium, Vascular metabolism, Sulfur, Garlic chemistry, Hydrogen Sulfide metabolism
- Abstract
A healthy vascular endothelium plays an essential role in modulating vascular tone by producing and releasing vasoactive factors such as nitric oxide (NO). Endothelial dysfunction (ED), the loss of the endothelium physiological functions, results in the inability to properly regulate vascular tone, leading to hypertension and other cardiovascular risk factors. Alongside NO, the gasotransmitter hydrogen sulfide (H
2 S) has emerged as a key molecule with vasodilatory and antioxidant activities. Since a reduction in H2 S bioavailability is related to ED pathogenesis, natural H2 S donors are very attractive. In particular, we focused on the sulfur-containing amino acid S -allyl cysteine (SAC), a bioactive metabolite, of which black garlic is particularly rich, with antioxidant activity and, among others, anti-diabetic and anti-hypertensive properties. In this study, we analyzed the protective effect of SAC against ED by evaluating reactive oxygen species level, H2 S release, eNOS phosphorylation, and NO production (by fluorescence imaging and western blot analysis) in Bovine Aortic Endothelial cells (BAE-1). Furthermore, we chemically characterized a Black Garlic Extract (BGE) for its content in SAC and other sulfur-containing amino acids. BGE was used to carry out an analysis on H2 S release on BAE-1 cells. Our results show that both SAC and BGE significantly increase H2 S release. Moreover, SAC reduces ROS production and enhances eNOS phosphorylation and the consequent NO release in our cellular model. In this scenario, a natural extract enriched in SAC could represent a novel therapeutic approach to prevent the onset of ED-related diseases.- Published
- 2023
- Full Text
- View/download PDF
9. Modulation of Endothelial Function by TMAO, a Gut Microbiota-Derived Metabolite.
- Author
-
Querio G, Antoniotti S, Geddo F, Levi R, and Gallo MP
- Subjects
- Humans, Methylamines metabolism, Gastrointestinal Microbiome physiology, Vascular Diseases
- Abstract
Endothelial function is essential in the maintenance of systemic homeostasis, whose modulation strictly depends on the proper activity of tissue-specific angiocrine factors on the physiopathological mechanisms acting at both single and multi-organ levels. Several angiocrine factors take part in the vascular function itself by modulating vascular tone, inflammatory response, and thrombotic state. Recent evidence has outlined a strong relationship between endothelial factors and gut microbiota-derived molecules. In particular, the direct involvement of trimethylamine N-oxide (TMAO) in the development of endothelial dysfunction and its derived pathological outcomes, such as atherosclerosis, has come to light. Indeed, the role of TMAO in the modulation of factors strictly related to the development of endothelial dysfunction, such as nitric oxide, adhesion molecules (ICAM-1, VCAM-1, and selectins), and IL-6, has been widely accepted. The aim of this review is to present the latest studies that describe a direct role of TMAO in the modulation of angiocrine factors primarily involved in the development of vascular pathologies.
- Published
- 2023
- Full Text
- View/download PDF
10. Trimethylamine N-Oxide (TMAO) Impairs Purinergic Induced Intracellular Calcium Increase and Nitric Oxide Release in Endothelial Cells.
- Author
-
Querio G, Antoniotti S, Geddo F, Levi R, and Gallo MP
- Subjects
- Adenosine Triphosphate, Animals, Calcium, Dietary, Cattle, Endothelial Cells metabolism, Humans, Methylamines, Reactive Oxygen Species metabolism, Calcium, Nitric Oxide metabolism
- Abstract
Trimethylamine N-oxide (TMAO) is a diet derived compound directly introduced through foodstuff, or endogenously synthesized from its precursors, primarily choline, L-carnitine, and ergothioneine. New evidence outlines high TMAO plasma concentrations in patients with overt cardiovascular disease, but its direct role in pathological development is still controversial. The purpose of the study was to evaluate the role of TMAO in affecting key intracellular factors involved in endothelial dysfunction development, such as reactive oxygen species, mitochondrial health, calcium balance, and nitric oxide release using bovine aortic endothelial cells (BAE-1). Cell viability and oxidative stress indicators were monitored after acute and prolonged TMAO treatment. The role of TMAO in interfering with the physiological purinergic vasodilatory mechanism after ATP stimulation was defined through measurements of the rise of intracellular calcium, nitric oxide release, and eNOS phosphorylation at Ser1179 (eNOS
Ser1179 ). TMAO was not cytotoxic for BAE-1 and it did not induce the rise of reactive oxygen species and impairment of mitochondrial membrane potential, either in the basal condition or in the presence of a stressor. In contrast, TMAO modified the purinergic response affecting intracellular ATP-induced calcium increase, nitric oxide release, and eNOSSer1179 . Results obtained suggest a possible implication of TMAO in impairing the endothelial-dependent vasodilatory mechanism.- Published
- 2022
- Full Text
- View/download PDF
11. Ischemic heart disease and cardioprotection: Focus on estrogenic hormonal setting and microvascular health.
- Author
-
Querio G, Antoniotti S, Geddo F, Tullio F, Penna C, Pagliaro P, and Gallo MP
- Subjects
- Estrogens, Estrone, Female, Heart, Humans, Male, Receptors, Estrogen, Myocardial Ischemia drug therapy, Myocardial Ischemia prevention & control
- Abstract
Ischemic Heart Disease (IHD) is a clinical condition characterized by insufficient blood flow to the cardiac tissue, and the consequent inappropriate oxygen and nutrients supply and metabolic waste removal in the heart. In the last decade a broad scientific literature has underlined the distinct mechanism of onset and the peculiar progress of IHD between female and male patients, highlighting the estrogenic hormonal setting as a key factor of these sex-dependent divergences. In particular, estrogen-activated cardioprotective pathways exert a pivotal role for the microvascular health, and their impairment, both physiologically and pathologically driven, predispose to vascular dysfunctions. Aim of this review is to summarize the current knowledge on the estrogen receptors localization and function in the cardiovascular system, particularly focusing on sex-dependent differences in microvascular vs macrovascular dysfunction and on the experimental models that allowed the researchers to reach the current findings and sketching the leading estrogen-mediated cardioprotective mechanisms., (Copyright © 2021. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
12. Sex and Response to Cardioprotective Conditioning Maneuvers.
- Author
-
Querio G, Geddo F, Antoniotti S, Gallo MP, and Penna C
- Abstract
Ischemic heart disease (IHD) is a multifactorial pathological condition strictly related to genetic, dietary, and lifestyle factors. Its morbidity and mortality rate represent one of the most important pathological issues that today involve younger people in a stronger way than in the past. IHD clinical outcomes are difficult to treat and have a high economic impact on health care. So prevention of this pathological condition through cardioprotective maneuvers represents the first line of intervention, as already underlined by several animal and human studies. Even if the time of intervention is important to prevent severe outcomes, many studies highlight that sex-dependent responses are crucial for the result of cardioprotective procedures. In this scenario sexual hormones have revealed an important role in cardioprotective approach, as women seem to be more protected toward cardiac insults when compared to male counterparts. The aim of this mini review is to show the molecular pathways involved in cardioprotective protocols and to elucidate how sexual hormones can contribute in ameliorating or worsening the physiological responses to IHD., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Querio, Geddo, Antoniotti, Gallo and Penna.)
- Published
- 2021
- Full Text
- View/download PDF
13. Plant-Derived Trans -β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation.
- Author
-
Geddo F, Antoniotti S, Querio G, Salaroglio IC, Costamagna C, Riganti C, and Gallo MP
- Subjects
- Animals, Cell Line, Electron Transport drug effects, Fluorescent Antibody Technique, Glycolysis drug effects, Mice, Mitochondria, Muscle drug effects, Mitochondria, Muscle metabolism, Muscle, Skeletal cytology, Muscle, Skeletal metabolism, Myoblasts drug effects, Myoblasts metabolism, Piper nigrum, Receptor, Cannabinoid, CB2 drug effects, Adenosine Triphosphate biosynthesis, Glucose metabolism, Muscle, Skeletal drug effects, Plant Extracts pharmacology, Polycyclic Sesquiterpenes pharmacology, Receptor, Cannabinoid, CB2 agonists
- Abstract
Skeletal muscle plays a pivotal role in whole-body glucose metabolism, accounting for the highest percentage of glucose uptake and utilization in healthy subjects. Impairment of these key functions occurs in several conditions including sedentary lifestyle and aging, driving toward hyperglycemia and metabolic chronic diseases. Therefore, strategies pointed to improve metabolic health by targeting skeletal muscle biochemical pathways are extremely attractive. Among them, we focused on the natural sesquiterpene and cannabinoid type 2 (CB2) receptor agonist Trans- β-caryophyllene (BCP) by analyzing its role in enhancing glucose metabolism in skeletal muscle cells. Experiments were performed on C2C12 myotubes. CB2 receptor membrane localization in myotubes was assessed by immunofluorescence. Within glucose metabolism, we evaluated glucose uptake (by the fluorescent glucose analog 2-NBDG), key enzymes of both glycolytic and oxidative pathways (by spectrophotometric assays and metabolic radiolabeling) and ATP production (by chemiluminescence-based assays). In all experiments, CB2 receptor involvement was tested with the CB2 antagonists AM630 and SR144528. Our results show that in myotubes, BCP significantly enhances glucose uptake, glycolytic and oxidative pathways, and ATP synthesis through a CB2-dependent mechanism. Giving these outcomes, CB2 receptor stimulation by BCP could represent an appealing tool to improve skeletal muscle glucose metabolism, both in physiological and pathological conditions.
- Published
- 2021
- Full Text
- View/download PDF
14. Protective Effects of ( E )-β-Caryophyllene (BCP) in Chronic Inflammation.
- Author
-
Scandiffio R, Geddo F, Cottone E, Querio G, Antoniotti S, Gallo MP, Maffei ME, and Bovolin P
- Subjects
- Animals, Humans, Inflammation Mediators metabolism, Oxidative Stress drug effects, PPAR gamma metabolism, Receptor, Cannabinoid, CB2 metabolism, Anti-Inflammatory Agents pharmacology, Chronic Disease drug therapy, Inflammation drug therapy, Plant Extracts pharmacology, Polycyclic Sesquiterpenes pharmacology
- Abstract
( E )-β-caryophyllene (BCP) is a bicyclic sesquiterpene widely distributed in the plant kingdom, where it contributes a unique aroma to essential oils and has a pivotal role in the survival and evolution of higher plants. Recent studies provided evidence for protective roles of BCP in animal cells, highlighting its possible use as a novel therapeutic tool. Experimental results show the ability of BCP to reduce pro-inflammatory mediators such as tumor necrosis factor-alfa (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), thus ameliorating chronic pathologies characterized by inflammation and oxidative stress, in particular metabolic and neurological diseases. Through the binding to CB2 cannabinoid receptors and the interaction with members of the family of peroxisome proliferator-activated receptors (PPARs), BCP shows beneficial effects on obesity, non-alcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) liver diseases, diabetes, cardiovascular diseases, pain and other nervous system disorders. This review describes the current knowledge on the biosynthesis and natural sources of BCP, and reviews its role and mechanisms of action in different inflammation-related metabolic and neurologic disorders., Competing Interests: The authors declare no conflict of interest. The funders had no role in the conceptualization and writing of the manuscript.
- Published
- 2020
- Full Text
- View/download PDF
15. Squalene: More than a Step toward Sterols.
- Author
-
Micera M, Botto A, Geddo F, Antoniotti S, Bertea CM, Levi R, Gallo MP, and Querio G
- Abstract
Squalene (SQ) is a natural triterpene widely distributed in nature. It is a metabolic intermediate of the sterol biosynthetic pathway and represents a possible target in different metabolic and oxidative stress-related disorders. Growing interest has been focused on SQ's antioxidant properties, derived from its chemical structure. Strong evidence provided by ex vivo models underline its scavenging activity towards free radicals, whereas only a few studies have highlighted its effect in cellular models of oxidative stress. Given the role of unbalanced free radicals in both the onset and progression of several cardiovascular diseases, an in depth evaluation of SQ's contribution to antioxidant defense mechanisms could represent a strategic approach in dealing with these pathological conditions. At present experimental results overall show a double-edged sword role of squalene in cardiovascular diseases and its function has to be better elucidated in order to establish intervention lines focused on its features. This review aims to summarize current knowledge about endogenous and exogenous sources of SQ and to point out the controversial role of SQ in cardiovascular physiology.
- Published
- 2020
- Full Text
- View/download PDF
16. Gradual weaning does not improve performance for calves with low starter intake at the beginning of the weaning process.
- Author
-
Bittar CMM, Gallo MP, Silva JT, de Paula MR, Poczynek M, and Mourão GB
- Subjects
- 3-Hydroxybutyric Acid blood, Animals, Cattle growth & development, Diet veterinary, Male, Random Allocation, Rumen physiology, Stress, Physiological, Vocalization, Animal, Animal Feed analysis, Behavior, Animal, Cattle physiology, Eating, Milk Substitutes metabolism, Weaning
- Abstract
The weaning process may cause intense stress for dairy calves, even when low volumes of liquid diet are fed. Management tools that increase the intake of solid feeds, such as gradual weaning, can provide better physiological and metabolic conditions through better ruminal development, leading to better adaptation to ruminant metabolism and aiding in stress mitigation. The objective of this study was to evaluate the effects of 2 weaning protocols and 2 levels of concentrate intake on the performance and physiological and behavioral variables related to stress in dairy calves. Thirty-six newborn male Holstein calves were used in a randomized block design with a 2 × 2 factorial arrangement: 2 weaning strategies, abrupt or gradual, and 2 levels of concentrate intake at 5 wk of age, high (>350 g/d) or low (≤350 g/d). Calves were equally managed until they were 5 wk of age and then grouped according to concentrate intake. Statistical analyzes were performed using the MIXED procedure of SAS software (SAS Institute Inc., Cary, NC), and no significant interaction was observed between studied factors (weaning method and starter intake level); therefore, we considered each factor separately and their interactions with age. The highest dry matter intake and concentration of β-hydroxybutyrate were recorded for animals with a high level of starter intake independent of the weaning method. Structural growth (cm/wk) and average daily gain were superior for calves with high starter intake, but weaning method had no effect. The gradual weaning protocol increased the time eating starter, regardless of the level of concentrate intake. Even animals with low concentrate intake that were weaned abruptly showed levels of cortisol and acid-soluble glycoprotein within normal physiological levels. Apparently, other factors besides the milk supply affect the starter intake level of calves in a conventional feeding program. The adoption of gradual weaning is not effective in improving performance when a calf has low intake 3 wk before weaning is complete, but it reduced vocalization on d 2 postweaning., (Copyright © 2020 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
17. PipeNig ® -FL, a Fluid Extract of Black Pepper ( Piper Nigrum L.) with a High Standardized Content of Trans -β-Caryophyllene, Reduces Lipid Accumulation in 3T3-L1 Preadipocytes and Improves Glucose Uptake in C2C12 Myotubes.
- Author
-
Geddo F, Scandiffio R, Antoniotti S, Cottone E, Querio G, Maffei ME, Bovolin P, and Gallo MP
- Subjects
- 3T3-L1 Cells, Adipocytes drug effects, Adipogenesis drug effects, Animals, Cell Differentiation drug effects, Cell Proliferation drug effects, Gas Chromatography-Mass Spectrometry, Glucose metabolism, Glucose Transporter Type 4 metabolism, Mice, Muscle Fibers, Skeletal drug effects, Plant Extracts chemistry, Lipid Metabolism drug effects, Piper nigrum chemistry, Plant Extracts pharmacology, Polycyclic Sesquiterpenes pharmacology
- Abstract
Trans -β-caryophyllene (BCP) is a natural sesquiterpene hydrocarbon with several important pharmacological activities, including antioxidant, anti-inflammatory, anticancer, and cardioprotective functions. These properties are mainly due to its selective interaction with the peripherally expressed cannabinoid receptor 2. In addition, BCP activates peroxisome proliferated activator receptors α and γ and inhibits the Toll-like receptor signaling pathway. Given the growing scientific interest in BCP, the aim of our study was to investigate the metabolic effects of a black pepper extract (PipeNig
® -FL), containing a high standardized content of BCP. In particular our interest was focused on its potential activity on lipid accumulation and glucose uptake. The extract PipeNig® -FL was chemically characterized by gas chromatography-mass spectrometry (GC-MS) and gas chromatography with flame-ionization detection (GC-FID), confirming a high content (814 mg/g) of BCP. Experiments were performed on 3T3-L1 preadipocytes and on C2C12 myotubes. Lipid content following 3T3-L1 adipogenic differentiation was quantified with AdipoRed fluorescence staining. Glucose uptake and GLUT4 membrane translocation were studied in C2C12 myotubes with the fluorescent glucose analog 2-NBDG and by immunofluorescence analysis. Here we show that PipeNig® -FL reduces 3T3-L1 adipocyte differentiation and lipid accumulation. Moreover, acute exposure of C2C12 myotubes to PipeNig® -FL improves glucose uptake activity and GLUT4 migration. Taken together, these results reveal interesting and novel properties of BCP, suggesting potential applications in the prevention of lipid accumulation and in the improvement of glucose uptake.- Published
- 2019
- Full Text
- View/download PDF
18. Trimethylamine N-Oxide Does Not Impact Viability, ROS Production, and Mitochondrial Membrane Potential of Adult Rat Cardiomyocytes.
- Author
-
Querio G, Antoniotti S, Levi R, and Gallo MP
- Subjects
- Animals, Cell Survival, Cells, Cultured, Female, Myocytes, Cardiac cytology, Rats, Membrane Potential, Mitochondrial, Methylamines metabolism, Myocytes, Cardiac metabolism, Reactive Oxygen Species metabolism
- Abstract
Trimethylamine N-oxide (TMAO) is an organic compound derived from dietary choline and L-carnitine. It behaves as an osmolyte, a protein stabilizer, and an electron acceptor, showing different biological functions in different animals. Recent works point out that, in humans, high circulating levels of TMAO are related to the progression of atherosclerosis and other cardiovascular diseases. However, studies on a direct role of TMAO in cardiomyocyte parameters are still limited. The purpose of this work is to study the effects of TMAO on isolated adult rat cardiomyocytes. TMAO in both 100 µM and 10 mM concentrations, from 1 to 24 h of treatment, does not affect cell viability, sarcomere length, intracellular ROS, and mitochondrial membrane potential. Furthermore, the simultaneous treatment with TMAO and known cardiac insults, such as H
2 O2 or doxorubicin, does not affect the treatment's effect. In conclusion, TMAO cannot be considered a direct cause or an exacerbating risk factor of cardiac damage at the cellular level in acute conditions., Competing Interests: The authors declare no conflict of interest.- Published
- 2019
- Full Text
- View/download PDF
19. Catestatin Induces Glucose Uptake and GLUT4 Trafficking in Adult Rat Cardiomyocytes.
- Author
-
Gallo MP, Femminò S, Antoniotti S, Querio G, Alloatti G, and Levi R
- Subjects
- Animals, Cell Membrane drug effects, Cell Membrane metabolism, Cell Movement drug effects, GTPase-Activating Proteins metabolism, Insulin metabolism, Myocytes, Cardiac metabolism, Phosphorylation drug effects, Protein Transport drug effects, Proto-Oncogene Proteins c-akt metabolism, Rats, Chromogranin A pharmacology, Glucose metabolism, Glucose Transporter Type 4 metabolism, Myocytes, Cardiac drug effects, Peptide Fragments pharmacology
- Abstract
Catestatin is a cationic and hydrophobic peptide derived from the enzymatic cleavage of the prohormone Chromogranin A. Initially identified as a potent endogenous nicotinic-cholinergic antagonist, Catestatin has recently been shown to act as a novel regulator of cardiac function and blood pressure and as a cardioprotective agent in both pre- and postconditioning through AKT-dependent mechanisms. The aim of this study is to investigate the potential role of Catestatin also on cardiac metabolism modulation, particularly on cardiomyocytes glucose uptake. Experiments were performed on isolated adult rat cardiomyocytes. Glucose uptake was assessed by fluorescent glucose incubation and confocal microscope analysis. Glut4 plasma membrane translocation was studied by immunofluorescence experiments and evaluation of the ratio peripheral vs internal Glut4 staining. Furthermore, we performed immunoblot experiments to investigate the involvement of the intracellular pathway AKT/AS160 in the Catestatin dependent Glut4 trafficking. Our results show that 10 nM Catestatin induces a significant increase in the fluorescent glucose uptake, comparable to that exerted by 100 nM Insulin. Moreover, Catestatin stimulates Glut4 translocation to plasma membrane and both AKT and AS160 phosphorylation. All these effects were inhibited by Wortmannin. On the whole, we show for the first time that Catestatin is able to modulate cardiac glucose metabolism, by inducing an increase in glucose uptake through Glut4 translocation to the plasma membrane and that this mechanism is mediated by the AKT/AS160 intracellular pathway.
- Published
- 2018
- Full Text
- View/download PDF
20. Chamazulene Attenuates ROS Levels in Bovine Aortic Endothelial Cells Exposed to High Glucose Concentrations and Hydrogen Peroxide.
- Author
-
Querio G, Antoniotti S, Foglietta F, Bertea CM, Canaparo R, Gallo MP, and Levi R
- Abstract
Endothelial cells surround the lumen of blood vessels and modulate many physiological processes, including vascular tone, blood fluidity, inflammation, immunity and neovascularization. Many pathological conditions, including hyperglycemia, may alter endothelial function through oxidative stress, leading to impaired nitric oxide bioavailability and to the onset of an inflammatory state. As widely shown in the last decade, dietary intervention could represent a good strategy to control endothelial dysfunction and atherosclerosis. In particular, extensive research in the field of antioxidant natural derivatives has been conducted. In this study, we evaluated the capability of Chamazulene (Cham), an azulene compound from chamomile essential oil, to attenuate ROS levels in bovine aortic endothelial cells (BAECs) stressed with either high glucose or H
2 O2 . Cell viability at different concentrations of Cham was evaluated through the WST-1 assay, while ROS production acutely induced by High Glucose (HG, 4.5 g/L) treatment or H2 O2 (0.5 mM) for 3 h, was quantified with 2'-7'-Dichlorofluorescein diacetate (DCFH-DA) probe using confocal microscopy and flow cytometry. Our results showed a reduction in ROS produced after simultaneous treatment with High Glucose or H2 O2 and Cham, thus suggesting an in vitro antioxidant activity of the compound. On the whole, this study shows for the first time the potential role of Cham as a scavenging molecule, suggesting its possible use to prevent the rise of endothelial ROS levels and the consequent vascular damage.- Published
- 2018
- Full Text
- View/download PDF
21. Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway.
- Author
-
Penna C, Tullio F, Femminò S, Rocca C, Angelone T, Cerra MC, Gallo MP, Gesmundo I, Fanciulli A, Brizzi MF, Pagliaro P, Alloatti G, and Granata R
- Subjects
- Animals, Cardiotonic Agents chemistry, Cardiotonic Agents metabolism, Cyclic GMP-Dependent Protein Kinases genetics, Cyclic GMP-Dependent Protein Kinases metabolism, Endothelin-1 antagonists & inhibitors, Endothelin-1 pharmacology, Gene Expression Regulation, Heart Ventricles drug effects, Heart Ventricles metabolism, Heart Ventricles pathology, Male, Myocardial Contraction drug effects, Myocardial Infarction genetics, Myocardial Infarction metabolism, Myocardial Infarction pathology, Myocardial Ischemia genetics, Myocardial Ischemia metabolism, Myocardial Ischemia pathology, Myocardial Reperfusion Injury genetics, Myocardial Reperfusion Injury metabolism, Myocardial Reperfusion Injury pathology, Organ Culture Techniques, Papillary Muscles drug effects, Papillary Muscles metabolism, Papillary Muscles pathology, Peptide Hormones genetics, Peptide Hormones metabolism, Phosphatidylinositol 3-Kinases genetics, Phosphatidylinositol 3-Kinases metabolism, Potassium Channels genetics, Potassium Channels metabolism, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-akt metabolism, Rats, Rats, Wistar, Signal Transduction, Soluble Guanylyl Cyclase genetics, Soluble Guanylyl Cyclase metabolism, Cardiotonic Agents pharmacology, Myocardial Infarction prevention & control, Myocardial Ischemia prevention & control, Myocardial Reperfusion Injury prevention & control, Nitric Oxide metabolism, Peptide Hormones pharmacology
- Abstract
Patients with ischaemic heart disease or chronic heart failure show altered levels of obestatin, suggesting a role for this peptide in human heart function. We have previously demonstrated that GH secretagogues and the ghrelin gene-derived peptides, including obestatin, exert cardiovascular effects by modulating cardiac inotropism and vascular tone, and reducing cell death and contractile dysfunction in hearts subjected to ischaemia/reperfusion (I/R), through the Akt/nitric oxide (NO) pathway. However, the mechanisms underlying the cardiac actions of obestatin remain largely unknown. Thus, we suggested that obestatin-induced activation of PI3K/Akt/NO and PKG signalling is implicated in protection of the myocardium when challenged by adrenergic, endothelinergic or I/R stress. We show that obestatin exerts an inhibitory tone on the performance of rat papillary muscle in both basal conditions and under β-adrenergic overstimulation, through endothelial-dependent NO/cGMP/PKG signalling. This pathway was also involved in the vasodilator effect of the peptide, used both alone and under stress induced by endothelin-1. Moreover, when infused during early reperfusion, obestatin reduced infarct size in isolated I/R rat hearts, through an NO/PKG pathway, comprising ROS/PKC signalling, and converging on mitochondrial ATP-sensitive potassium [mitoK(ATP)] channels. Overall, our results suggest that obestatin regulates cardiovascular function in stress conditions and induces cardioprotection by mechanisms dependent on activation of an NO/soluble guanylate cyclase (sGC)/PKG pathway. In fact, obestatin counteracts exaggerated β-adrenergic and endothelin-1 activity, relevant factors in heart failure, suggesting multiple positive effects of the peptide, including the lowering of cardiac afterload, thus representing a potential candidate in pharmacological post-conditioning., (© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.)
- Published
- 2017
- Full Text
- View/download PDF
22. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
- Author
-
Gesmundo I, Miragoli M, Carullo P, Trovato L, Larcher V, Di Pasquale E, Brancaccio M, Mazzola M, Villanova T, Sorge M, Taliano M, Gallo MP, Alloatti G, Penna C, Hare JM, Ghigo E, Schally AV, Condorelli G, and Granata R
- Subjects
- Animals, Apoptosis drug effects, Calcineurin metabolism, Cardiomegaly chemically induced, Cell Line, Cyclic AMP-Dependent Protein Kinases metabolism, Humans, Male, Mice, Mice, Inbred C57BL, Myocardium metabolism, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Phenylephrine pharmacology, Phospholipase C beta metabolism, Protein Kinase C metabolism, Rats, Signal Transduction drug effects, Cardiomegaly metabolism, Growth Hormone-Releasing Hormone metabolism, Heart physiology, Heart Failure metabolism
- Abstract
It has been shown that growth hormone-releasing hormone (GHRH) reduces cardiomyocyte (CM) apoptosis, prevents ischemia/reperfusion injury, and improves cardiac function in ischemic rat hearts. However, it is still not known whether GHRH would be beneficial for life-threatening pathological conditions, like cardiac hypertrophy and heart failure (HF). Thus, we tested the myocardial therapeutic potential of GHRH stimulation in vitro and in vivo, using GHRH or its agonistic analog MR-409. We show that in vitro, GHRH(1-44)NH
2 attenuates phenylephrine-induced hypertrophy in H9c2 cardiac cells, adult rat ventricular myocytes, and human induced pluripotent stem cell-derived CMs, decreasing expression of hypertrophic genes and regulating hypertrophic pathways. Underlying mechanisms included blockade of Gq signaling and its downstream components phospholipase Cβ, protein kinase Cε, calcineurin, and phospholamban. The receptor-dependent effects of GHRH also involved activation of Gαs and cAMP/PKA, and inhibition of increase in exchange protein directly activated by cAMP1 (Epac1). In vivo, MR-409 mitigated cardiac hypertrophy in mice subjected to transverse aortic constriction and improved cardiac function. Moreover, CMs isolated from transverse aortic constriction mice treated with MR-409 showed improved contractility and reversal of sarcolemmal structure. Overall, these results identify GHRH as an antihypertrophic regulator, underlying its therapeutic potential for HF, and suggest possible beneficial use of its analogs for treatment of pathological cardiac hypertrophy., Competing Interests: Conflict of interest statement: A.V.S. is a coinventor on the Patent for growth hormone-releasing hormone agonists, assigned to the University of Miami, FL, and the Veterans Affairs Medical Center, Miami, FL. J.M.H. owns equity in Biscayne Pharmaceuticals Inc. (Miami, FL). Biscayne Pharmaceuticals did not provide funding for this study., (Copyright © 2017 the Author(s). Published by PNAS.)- Published
- 2017
- Full Text
- View/download PDF
23. Performance and Metabolism of Calves Fed Starter Feed Containing Sugarcane Molasses or Glucose Syrup as a Replacement for Corn.
- Author
-
Oltramari CE, Nápoles GG, De Paula MR, Silva JT, Gallo MP, Pasetti MH, and Bittar CM
- Abstract
The aim of this study was to evaluate the effect of replacing corn grain for sugar cane molasses (MO) or glucose syrup (GS) in the starter concentrate on performance and metabolism of dairy calves. Thirty-six individually housed Holstein male calves were blocked according to weight and date of birth and assigned to one of the starter feed treatments, during an 8 week study: i) starter containing 65% corn with no MO or GS (0MO); ii) starter containing 60% corn and 5% MO (5MO); iii) starter containing 55% corn and 10% MO (10MO); and iv) starter containing 60% corn and 5% GS (5GS). Animals received 4 L of milk replacer daily (20 crude protein, 16 ether extract, 12.5% solids), divided in two meals (0700 and 1700 h). Starter and water were provided ad libitum. Starter intake and fecal score were monitored daily until animals were eight weeks old. Body weight and measurements (withers height, hip width and heart girth) were measured weekly before the morning feeding. From the second week of age, blood samples were collected weekly, 2 h after the morning feeding, for glucose, β-hydroxybutyrate and lactate determination. Ruminal fluid was collected at 4, 6, and 8 weeks of age using an oro-ruminal probe and a suction pump for determination of pH and short-chain fatty acids (SCFA). At the end of the eighth week, animals were harvested to evaluate development of the proximal digestive tract. The composition of the starter did not affect (p>0.05) concentrate intake, weight gain, fecal score, blood parameters, and rumen development. However, treatment 5MO showed higher (p<0.05) total concentration of SCFAs, acetate and propionate than 0MO, and these treatments did not differ from 10MO and 5GS (p>0.05). Thus, it can be concluded that the replacement of corn by 5% or 10% sugar cane molasses or 5% GS on starter concentrate did not impact performance, however it has some positive effects on rumen fermentation which may be beneficial for calves with a developing rumen.
- Published
- 2016
- Full Text
- View/download PDF
24. Squaraines bearing halogenated moieties as anticancer photosensitizers: Synthesis, characterization and biological evaluation.
- Author
-
Serpe L, Ellena S, Barbero N, Foglietta F, Prandini F, Gallo MP, Levi R, Barolo C, Canaparo R, and Visentin S
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Death drug effects, Cell Proliferation drug effects, Cyclobutanes chemical synthesis, Cyclobutanes chemistry, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Humans, Models, Molecular, Molecular Structure, Phenols chemical synthesis, Phenols chemistry, Photosensitizing Agents chemical synthesis, Photosensitizing Agents chemistry, Reactive Oxygen Species metabolism, Structure-Activity Relationship, Tumor Cells, Cultured, Antineoplastic Agents pharmacology, Cyclobutanes pharmacology, Halogens chemistry, Phenols pharmacology, Photosensitizing Agents pharmacology
- Abstract
We report the synthesis and characterization of a series of symmetrical indolenine-based squaraine dyes along with the evaluation of their singlet oxygen generation efficiency. The photodynamic activity of these new photosensitizers has been evaluated on a human tumor fibrosarcoma (HT-1080) cell line. The cytotoxicity increased over time and is induced by the photoactivation of bromo (Br-C4) and iodio (I-C4) long carbon chain squaraine dyes and the consequent increase in reactive oxygen species (ROS) production (p < 0.001), which leads to necrosis 6 h after treatment. Induction of cytochrome c release, DNA damage and up-regulation of GPX1, NQO1 and SOD2 mRNA gene expression after PDT were investigated., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
25. Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential.
- Author
-
Bassino E, Fornero S, Gallo MP, Gallina C, Femminò S, Levi R, Tota B, and Alloatti G
- Subjects
- Animals, Cell Survival drug effects, Chromogranin A therapeutic use, Glycogen Synthase Kinase 3 metabolism, Myocardial Reperfusion Injury metabolism, Myocardial Reperfusion Injury pathology, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Peptide Fragments therapeutic use, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-akt metabolism, Rats, Chromogranin A pharmacology, Membrane Potential, Mitochondrial drug effects, Myocardial Reperfusion Injury drug therapy, Myocytes, Cardiac drug effects, Peptide Fragments pharmacology, Signal Transduction drug effects
- Abstract
Catestatin (Cst) is a 21-amino acid peptide deriving from Chromogranin A. Cst exerts an overall protective effect against an excessive sympathetic stimulation of cardiovascular system, being able to antagonize catecholamine secretion and to reduce their positive inotropic effect, by stimulating the release of nitric oxide (NO) from endothelial cells. Moreover, Cst reduces ischemia/reperfusion (I/R) injury, improving post-ischemic cardiac function and cardiomyocyte survival. To define the cardioprotective signaling pathways activated by Cst (5 nM) we used isolated adult rat cardiomyocytes undergoing simulated I/R. We evaluated cell viability rate with propidium iodide labeling and mitochondrial membrane potential (MMP) with the fluorescent probe JC-1. The involvement of Akt, GSK3β, eNOS and phospholamban (PLN) cascade was studied by immunofluorescence. The role of PI3K-Akt/NO/cGMP pathway was also investigated by using the pharmacological blockers wortmannin (Wm), L-NMMA and ODQ. Our experiments revealed that Cst increased cell viability rate by 65% and reduced cell contracture in I/R cardiomyocytes. Wm, L-NMMA and ODQ limited the protective effect of Cst. The protective outcome of Cst was related to its ability to maintain MMP and to increase AktSer473, GSK3βSer9, PLNThr17 and eNOSSer1179 phosphorylation, while treatment with Wm abolished these effects. Thus, the present results show that Cst is able to exert a direct action on cardiomyocytes and give new insights into the molecular mechanisms involved in its protective effect, highlighting the PI3K/NO/cGMP pathway as the trigger and the MMP preservation as the end point of its action.
- Published
- 2015
- Full Text
- View/download PDF
26. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
- Author
-
Penna C, Granata R, Tocchetti CG, Gallo MP, Alloatti G, and Pagliaro P
- Subjects
- Animals, Carbon Monoxide metabolism, Gasotransmitters metabolism, Humans, Hydrogen Sulfide metabolism, Myocardial Ischemia metabolism, Myocardial Reperfusion Injury metabolism, Myocardial Reperfusion Injury therapy, Nitric Oxide metabolism, Cardiotonic Agents metabolism, Ischemic Postconditioning methods, Ischemic Preconditioning, Myocardial methods, Myocardial Ischemia prevention & control, Myocardial Reperfusion Injury prevention & control
- Abstract
Cardiovascular diseases (CVD) are the leading cause of death, chronic illness and disability in Western countries. The most common cause of CVD derives from the harmful effects of acute myocardial ischemia and subsequent reperfusion injury. Cardioprotection against acute ischemia/ reperfusion injury is made possible by the "conditioning protocols." Conditioning is obtained by applying a few periods of brief ischemia and reperfusion in the event of prolonged (index) ischemia that may cause myocardial infarction. Whilst the conditioning stimulus is applied before the index ischemia in ischemic pre-conditioning, it is applied after the event in post-conditioning. Pre and post- conditioning stimuli can be applied in a different/remote organ (remote pre- and post-conditioning); in this case conditioning stimulus can also be applied during the index event, in the so called remote per-conditioning. All these endogenous cardioprotective strategies recruit endogenous cytoprotective agents and factors that elicit specific cardioprotective pathways. Here, we discuss many of these cardioprotective factors compared to literature and highlight their main characteristics and mechanisms of action. Enphasis is given to endogenous cardioprotective agents acting or not on surface receptors, including chromogranin A derivatives, ghrelin-associated peptides, growth factors and cytokines, and to microvesicles and exosomes. Moreover the cardioprotective effects of gasotransmitters nitric oxide, hydrogen sulphide and carbon monoxide are reviewed. The possible clinical translation of these knowledge for future successful therapies is briefly and critically discussed.
- Published
- 2015
- Full Text
- View/download PDF
27. RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion.
- Author
-
Granata R, Settanni F, Trovato L, Gallo D, Gesmundo I, Nano R, Gallo MP, Bergandi L, Volante M, Alloatti G, Piemonti L, Leprince J, Papotti M, Vaudry H, Ong H, and Ghigo E
- Subjects
- Animals, Apoptosis drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Cells, Cultured, Humans, Insulin Secretion, Insulin-Secreting Cells physiology, Intercellular Signaling Peptides and Proteins, Islets of Langerhans physiology, Peptides genetics, Peptides metabolism, Rats, Receptors, G-Protein-Coupled genetics, Receptors, G-Protein-Coupled metabolism, Insulin metabolism, Insulin-Secreting Cells drug effects, Islets of Langerhans drug effects, Neuropeptides pharmacology
- Abstract
RFamide peptides 43RFa and 26RFa have been shown to promote food intake and to exert different peripheral actions through G-protein-coupled receptor 103 (GPR103) binding. Moreover, 26RFa was found to inhibit pancreatic insulin secretion, whereas the role of 43RFa on β-cell function is unknown, as well as the effects of both peptides on β-cell survival. Herein, we investigated the effects of 43RFa and 26RFa on survival and apoptosis of pancreatic β-cells and human pancreatic islets. In addition, we explored the role of these peptides on insulin secretion and the underlying signaling mechanisms. Our results show that in INS-1E β-cells and human pancreatic islets both 43RFa and 26RFa prevented cell death and apoptosis induced by serum starvation, cytokine synergism, and glucolipotoxicity, through phosphatidylinositol 3-kinase/Akt- and extracellular signal-related kinase 1/2-mediated signaling. Moreover, 43RFa promoted, whereas 26RFa inhibited, glucose- and exendin-4-induced insulin secretion, through Gαs and Gαi/o proteins, respectively. Inhibition of GPR103 expression by small interfering RNA blocked 43RFa insulinotropic effect, but not the insulinostatic action of 26RFa. Finally, 43RFa, but not 26RFa, induced cAMP increase and glucose uptake. In conclusion, because of their survival effects along with the effects on insulin secretion, these findings suggest potential for 43RFa and 26RFa as therapeutic targets in the treatment of diabetes., (© 2014 by the American Diabetes Association.)
- Published
- 2014
- Full Text
- View/download PDF
28. Obligatory role for endothelial heparan sulphate proteoglycans and caveolae internalization in catestatin-dependent eNOS activation.
- Author
-
Fornero S, Bassino E, Ramella R, Gallina C, Mahata SK, Tota B, Levi R, Alloatti G, and Gallo MP
- Subjects
- Animals, Aorta drug effects, Aorta metabolism, Cattle, Caveolae drug effects, Caveolae ultrastructure, Caveolin 1 metabolism, Chromogranin A metabolism, Chromogranin A ultrastructure, Endothelial Cells drug effects, Endothelial Cells ultrastructure, Nitric Oxide Synthase Type III metabolism, Peptide Fragments metabolism, Peptide Fragments ultrastructure, Transport Vesicles metabolism, Transport Vesicles ultrastructure, Chromogranin A administration & dosage, Endocytosis drug effects, Heparan Sulfate Proteoglycans metabolism, Nitric Oxide metabolism, Peptide Fragments administration & dosage
- Abstract
The chromogranin-A peptide catestatin modulates a wide range of processes, such as cardiovascular functions, innate immunity, inflammation, and metabolism. We recently found that the cardiac antiadrenergic action of catestatin requires a PI3K-dependent NO release from endothelial cells, although the receptor involved is yet to be identified. In the present work, based on the cationic properties of catestatin, we tested the hypothesis of its interaction with membrane heparan sulphate proteoglycans, resulting in the activation of a caveolae-dependent endocytosis. Experiments were performed on bovine aortic endothelial cells. Endocytotic vesicles trafficking was quantified by confocal microscopy using a water-soluble membrane dye; catestatin colocalization with heparan sulphate proteoglycans and caveolin 1 internalization were studied by fluorimetric measurements in live cells. Modulation of the catestatin-dependent eNOS activation was assessed by immunofluorescence and immunoblot analysis. Our results demonstrate that catestatin (5 nM) colocalizes with heparan sulphate proteoglycans and induces a remarkable increase in the caveolae-dependent endocytosis and caveolin 1 internalization, which were significantly reduced by both heparinase and wortmannin. Moreover, catestatin was unable to induce Ser(1179) eNOS phosphorylation after pretreatments with heparinase and methyl-β-cyclodextrin. Taken together, these results highlight the obligatory role for proteoglycans and caveolae internalization in the catestatin-dependent eNOS activation in endothelial cells.
- Published
- 2014
- Full Text
- View/download PDF
29. Development of morphology and function of neonatal mouse ventricular myocytes cultured on a hyaluronan-based polymer scaffold.
- Author
-
Gallina C, Dolgetta S, Alloatti G, Levi R, and Gallo MP
- Subjects
- Animals, Animals, Newborn, Cell Adhesion, Cell Separation, Cells, Cultured, Heart Ventricles cytology, Mice, Hyaluronic Acid, Myocytes, Cardiac cytology, Myocytes, Cardiac physiology, Tissue Scaffolds
- Abstract
In recent years cardiac tissue engineering has emerged as a promising field aimed at developing suitable techniques to repair the infarcted myocardium with a combination of cells, biomaterials, and regulative factors. In particular it could stand for an alternative strategy to simple in situ cellular implantation. In the present study our purpose was to analyze the interaction between a hyaluronan-based mesh (HYALONECT®) and neonatal murine ventricular myocytes (NMVMs). Specifically, we investigated morphological and functional characteristics of cardiomyocytes cultured on HYALONECT® in view of its employment in heart repair. Both living and fixed cells analysis was performed on in toto scaffolds with confocal microscopy. NMVMs adhesion on HYALONECT® was studied by tracking sarcomeric α-actinin immunofluorescence staining. The structural features of NMVMs adherent onto HYALONECT® were investigated at 24, 48, 72 h, and 7 days of culture by immunofluorescence for sarcomeric α-actinin and connexin-43. We observed a progressive morphological organization of the cells inside the biopolymer, with both clear sarcomeric arrangement along the scaffold fibers and gap junctions development between adjacent cells. Finally, in vivo intracellular calcium measurements performed using calcium fluorimetric confocal imaging revealed the presence of spontaneous calcium transients and contractile activity of NMVMs adherent onto HYALONECT® up to 48 h from seeding, indicating a progressive differentiation of the cells toward the adult phenotype. In conclusion, our results demonstrate that HYALONECT® allowed NMVMs to adhere to the fibers and to develop functional properties, displaying suitable features as a scaffold to perform heart tissue engineering., (Copyright © 2011 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
30. Endothelium dependent cardiovascular effects of the Chromogranin A-derived peptides Vasostatin-1 and Catestatin.
- Author
-
Fornero S, Bassino E, Gallo MP, Ramella R, Levi R, and Alloatti G
- Subjects
- Endocytosis, Humans, Myocytes, Cardiac metabolism, Nitric Oxide metabolism, Nitric Oxide Synthase Type III metabolism, Signal Transduction, Chromogranin A metabolism, Endothelium, Vascular metabolism, Peptide Fragments metabolism
- Abstract
The involvement of Chromogranin A (CgA) in the cardiovascular function regulation is attributed to its function as a prohormone. Several studies indicated that CgA-derived peptides, particularly Vasostatin-1 (VS-1) and Catestatin (CST), exert signaling effects in numerous organs/systems, including the cardiovascular system. This review focuses on the recently described signaling pathways activated by VS-1 and CST, giving insights into the mechanisms at the basis of their cardiac negative inotropic action, their vasodilator effects and their cardioprotective role observed in different experimental conditions. Accumulated evidences provided convincing support for VS-1 and CST as vasoactive peptides indirectly acting on cardiomyocytes through a Ca(2+)-independent/PI3-K-dependent NO release from endothelial cells. This pathway is supposed to be triggered by the interaction of these peptides with the plasma membrane. The premise of these studies grounds on the biochemical features of VS-1 and CST, which are structurally characterized by amphipathic properties and the ability to interact with mammalian and microbial membranes. On the other hand, recent data obtained in both isolated heart and isolated cardiomyocytes suggest that the VS-1 and CST-mediated cardioprotective effects are primarily direct on the myocardium, rather than endothelium-dependent. Anyway, both direct and indirect pathways seem to be characterized by the absence of specific membrane receptors on target cells, highlighting intriguing novelties in the topic of cell signaling, in particular respect to an hypothetical receptor-independent eNOS activation.
- Published
- 2012
- Full Text
- View/download PDF
31. Regulation of intracellular cardiomyocyte calcium stores by peptides: a new approach to cardiac protection.
- Author
-
Gallina C, Brero A, Gallo MP, and Levi R
- Subjects
- Calcium Signaling, Humans, Mitochondria metabolism, Neuregulin-1 metabolism, Receptor, ErbB-2 metabolism, Sarcoplasmic Reticulum metabolism, Sarcoplasmic Reticulum Calcium-Transporting ATPases metabolism, Urocortins metabolism, Calcium metabolism, Myocytes, Cardiac metabolism, Peptides metabolism
- Abstract
The control of cytosolic calcium is a major determinant not only of cardiac function, but also of the capability of myocardial tissue to survive damage. Increase of diastolic calcium leads rapidly to cell injury, and may be induced by a wide range of causes. In this review we describe the major points of calcium control in cardiac myocytes, mainly in mammalian ventricle, focusing on mechanisms of intracellular calcium influx during excitation, voltage gated channels of the sarcolemma and ryanodine receptors of the sarcoplasmic reticulum (SR), and efflux during relaxation, principally the sodium/calcium exchanger in membrane and the SR calcium complex. Mitochondria also depend on calcium concentration while also participating in its control. Moreover, we will outline receptor check points and their roles in physiology and pathology. We will focus on some new aspects of potential protective mechanisms that have been recently described and that involve peptide ligands and that in the case of the Neuregulin1beta/ErbB pathway are already reaching the clinical trial relevance.
- Published
- 2012
- Full Text
- View/download PDF
32. A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium.
- Author
-
Bassino E, Fornero S, Gallo MP, Ramella R, Mahata SK, Tota B, Levi R, and Alloatti G
- Subjects
- Animals, Blotting, Western, Calcium metabolism, Cattle, Cells, Cultured, Fluorescent Antibody Technique, Myocardium metabolism, Nitric Oxide biosynthesis, Papillary Muscles drug effects, Rats, Adrenergic Antagonists pharmacology, Chromogranin A pharmacology, Heart drug effects, Nitric Oxide Synthase Type III physiology, Peptide Fragments pharmacology, Phosphatidylinositol 3-Kinases physiology, Signal Transduction drug effects
- Abstract
Aims: Catestatin (CST) is a chromogranin A (CgA)-derived peptide (hCgA352-372) with three identified human variants (G364S/P370L/R374Q-CST) that show differential potencies towards the inhibition of catecholamine release. Although CST affects several cardiovascular parameters, the mechanisms underlying CST action in the heart have remained elusive. Therefore, we sought to determine the mechanism of action of CST and its variants on ventricular myocardium and endothelial cells., Methods and Results: Contractile force and Ca(2+) transients were measured, respectively, on rat papillary muscles and isolated cardiomyocytes (CC) under basal conditions and after β-adrenergic stimulation. Nitric oxide (NO) production and endothelial nitric oxide synthase (eNOS) phosphorylation (P(Ser1179)eNOS) were studied in bovine aortic endothelial (BAE-1) cells. Under basal conditions, wild-type CST (WT-CST, 10-50 nM) transiently enhanced myocardial contractility. CST variants (G364S and P370L) exerted a comparable positive inotropic effect. The H(1) histamine receptor antagonist mepyramine abolished the increase of contractile force induced by WT-CST. Moreover, WT-CST dose-dependently (5-50 nM) reduced the effect of β-adrenergic stimulation. This anti-adrenergic effect was not mediated by a direct action on CC, but involved a PI3K-dependent NO release from endocardial endothelial cells. Indeed, CST induced a wortmannin-sensitive, Ca(2+)-independent increase in NO production and eNOS phosphorylation on BAE-1 cells. While the anti-adrenergic and NO release effects of P370L-CST were comparable with those of WT-CST, the G364S variant was ineffective on the same parameters., Conclusion: Our results suggest that the anti-adrenergic action of CST depends on the endothelial PI3K-Akt-eNOS pathway and that its structural alterations entail functional features that correlate with the different anti-hypertensive potential described in humans.
- Published
- 2011
- Full Text
- View/download PDF
33. A novel role of thrombopoietin as a physiological modulator of coronary flow.
- Author
-
Ramella R, Gallo MP, Spatola T, Lupia E, and Alloatti G
- Subjects
- Androstadienes pharmacology, Animals, Blotting, Western, Cells, Cultured, Endothelial Cells metabolism, Endothelin-1 pharmacology, Gene Expression, Heart drug effects, Heart physiology, Humans, NG-Nitroarginine Methyl Ester pharmacology, Nitric Oxide metabolism, Nitric Oxide Synthase Type III genetics, Organ Culture Techniques, Phosphorylation drug effects, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-akt metabolism, Rats, Receptors, Thrombopoietin genetics, Thrombopoietin genetics, Thrombopoietin pharmacology, Vasoconstriction drug effects, Wortmannin, Coronary Circulation drug effects, Nitric Oxide Synthase Type III metabolism, Receptors, Thrombopoietin metabolism, Thrombopoietin metabolism
- Abstract
Thrombopoietin (TPO) is known for its ability to stimulate platelet production. However, little is currently known whether TPO plays a physiological function in the heart. The potential vasodilatory role of TPO was tested on the isolated rat heart. The expression of TPO receptor (c-mpl) and the TPO-dependent eNOS phosphorylation (P(Ser1179)) were studied on Cardiac-derived normal Human Micro Vascular Endothelial Cells (HMVEC-C) by Western blot analysis. While TPO (10-200 pg/mL) did not modify coronary flow (CF) under basal conditions, it reduced the coronary constriction caused by endothelin-1 (ET-1; 10nM) in a dose-dependent manner. This effect was blocked by both Wortmannin (100 nM) and L-NAME (100 nM); on HMVEC-C, TPO induced eNOS phosphorylation through a Wortmannin sensitive mechanism. Taken together, our data suggest a potential role of TPO as a physiological regulator of CF. By acting on specific receptors present on endothelial cells, TPO may induce PI3K/Akt-dependent eNOS phosphorylation and NO release., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
34. Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes.
- Author
-
Brero A, Ramella R, Fitou A, Dati C, Alloatti G, Gallo MP, and Levi R
- Subjects
- Androstadienes pharmacology, Animals, Calcium-Binding Proteins metabolism, Cyclic GMP-Dependent Protein Kinases antagonists & inhibitors, Cyclic GMP-Dependent Protein Kinases metabolism, Female, Fluoresceins pharmacology, Models, Animal, Myocytes, Cardiac cytology, Nitric Oxide Synthase Type III metabolism, Peptide Fragments pharmacology, Phosphatidylinositol 3-Kinases metabolism, Phosphoinositide-3 Kinase Inhibitors, Protein Kinase Inhibitors pharmacology, Rats, Rats, Inbred Strains, Sarcoplasmic Reticulum metabolism, Wortmannin, Calcium metabolism, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Neuregulin-1 pharmacology, Nitric Oxide metabolism
- Abstract
Aims: The ErbB-neuregulin-1β1 (Nrg1β1) pathway is required for cardiac development and exerts chronic effects on the postnatal adult heart. Long-term application of Nrg1β1 results in hypertrophy and protection against oxidative stress and cytotoxic agents. We performed experiments with acute Nrg1β1 treatment to find evidence for a further protective role due to rapid modulation of adult cardiomyocyte function., Methods and Results: In confocal fluorimetric measurements, Nrg1β1 induced a calcium-independent increase in nitric oxide (NO) production in isolated adult rat ventricular myocytes (ARVCMs) that was blocked by the phosphoinositide-3-kinase (PI3K) inhibitor Wortmannin. Western blot analysis showed enhancement of endothelial nitric oxide synthase phosphorylation in Nrg1β1-treated ARVCMs, which was attenuated by Wortmannin. Nrg1β1 induced a significant increase in calcium transient amplitude (indo-1 ratiometric measurement) and accelerated the recovery of cytosolic calcium in the sarcoplasmic reticulum without affecting whole-cell L-type calcium current. Wortmannin or the protein kinase G inhibiting peptide (DT-2) abolished the increase in calcium transient amplitude and the acceleration of calcium recovery induced by Nrg1β1 treatment. Immunofluorescence analysis revealed that Nrg1β1 treatment increased phospholamban phosphorylation, and the effect was blocked by PI3K and protein kinase G inhibition. Caffeine-releasable sarcoplasmic reticulum calcium content was also higher during Nrg1β1 administration., Conclusion: Rapid activation of PI3K, endothelial nitric oxide synthase and protein kinase G and a consequent improvement in diastolic calcium can be added to established Nrg1 protective roles.
- Published
- 2010
- Full Text
- View/download PDF
35. Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart.
- Author
-
Penna C, Alloatti G, Gallo MP, Cerra MC, Levi R, Tullio F, Bassino E, Dolgetta S, Mahata SK, Tota B, and Pagliaro P
- Subjects
- Animals, Cell Separation, Cell Survival, Chromogranin A therapeutic use, Diastole drug effects, Heart Function Tests drug effects, In Vitro Techniques, Male, Myocardial Infarction complications, Myocardial Infarction pathology, Myocardial Infarction physiopathology, Myocardial Ischemia complications, Myocytes, Cardiac drug effects, Myocytes, Cardiac pathology, Peptide Fragments therapeutic use, Rats, Rats, Wistar, Reperfusion Injury complications, Systole drug effects, Chromogranin A pharmacology, Heart physiopathology, Myocardial Ischemia drug therapy, Myocardial Ischemia physiopathology, Peptide Fragments pharmacology, Reperfusion Injury drug therapy, Reperfusion Injury physiopathology, Ventricular Function, Left drug effects
- Abstract
The Chromogranin A (CgA)-derived anti-hypertensive peptide catestatin (CST) antagonizes catecholamine secretion, and is a negative myocardial inotrope acting via a nitric oxide-dependent mechanism. It is not known whether CST contributes to ischemia/reperfusion injury or is a component of a cardioprotective response to limit injury. Here, we tested whether CST by virtue of its negative inotropic activity improves post-ischemic cardiac function and cardiomyocyte survival. Three groups of isolated perfused hearts from adult Wistar rats underwent 30-min ischemia and 120-min reperfusion (I/R, Group 1), or were post-conditioned by brief ischemic episodes (PostC, 5-cycles of 10-s I/R at the beginning of 120-min reperfusion, Group 2), or with exogenous CST (75 nM for 20 min, CST-Post, Group-3) at the onset of reperfusion. Perfusion pressure and left ventricular pressure (LVP) were monitored. Infarct size was evaluated with nitroblue-tetrazolium staining. The CST (5 nM) effects were also tested in simulated ischemia/reperfusion experiments on cardiomyocytes isolated from young-adult rats, evaluating cell survival with propidium iodide labeling. Infarct size was 61 ± 6% of risk area in hearts subjected to I/R only. PostC reduced infarct size to 34 ± 5%. Infarct size in CST-Post was 36 ± 3% of risk area (P < 0.05 respect to I/R). CST-Post reduced post-ischemic rise of diastolic LVP, an index of contracture, and significantly improved post-ischemic recovery of developed LVP. In isolated cardiomyocytes, CST increased the cell viability rate by about 65% after simulated ischemia/reperfusion. These results suggest a novel cardioprotective role for CST, which appears mainly due to a direct reduction of post-ischemic myocardial damages and dysfunction, rather than to an involvement of adrenergic terminals and/or endothelium.
- Published
- 2010
- Full Text
- View/download PDF
36. Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan-dependent mechanism.
- Author
-
Ramella R, Boero O, Alloatti G, Angelone T, Levi R, and Gallo MP
- Subjects
- Androstadienes pharmacology, Animals, Cattle, Caveolae drug effects, Caveolae metabolism, Caveolin 1 metabolism, Endocytosis drug effects, Enzyme Activation drug effects, Heparin Lyase pharmacology, Phosphatidylinositol 3-Kinases metabolism, Phosphorylation drug effects, Protein Transport drug effects, Transport Vesicles drug effects, Transport Vesicles metabolism, Wortmannin, Chromogranin A pharmacology, Endothelial Cells drug effects, Endothelial Cells enzymology, Nitric Oxide Synthase Type III metabolism, Peptide Fragments pharmacology, Proteoglycans metabolism
- Abstract
Accumulating evidences point to a significant role for the chromogranin A (CgA)-derived peptide vasostatin 1 (VS-1) in the protective modulation of the cardiovascular activity, because of its ability to counteract the adrenergic signal. We have recently shown that VS-1 induces a PI3K-dependent-nitric oxide (NO) release by endothelial cells, contributing to explain the mechanism of its cardio-suppressive and vasodilator properties. However, the cellular processes upstream the eNOS activation exerted by this peptide are still unknown, as typical high-affinity receptors have not been identified. Here we hypothesize that in endothelial cells VS-1 acts, on the basis of its cationic and amphipathic properties, as a cell penetrating peptide, binding to heparan sulfate proteoglycans (HSPGs) and activating eNOS phosphorylation (Ser1179) through a PI3K-dependent, endocytosis-coupled mechanism. In bovine aortic endothelial cells (BAE-1 cells) endocytotic vesicles trafficking was quantified by confocal microscopy with a water-soluble membrane dye; caveolin 1 (Cav1) shift from plasma membrane was studied by immunofluorescence staining; VS-1-dependent eNOS phosphorylation was assessed by immunofluorescence and immunoblot analysis. Our experiments demonstrate that VS-1 induces a marked increase in the caveolae-dependent endocytosis, (115 +/- 23% endocytotic spots/cell/field in VS-1-treated cells with respect to control cells), that is significantly reduced by both heparinase III (HEP, 17 +/- 15% above control) and Wortmannin (Wm, 7 +/- 22% above control). Heparinase, Wortmannin, and methyl-beta-cyclodextrin (MbetaCD) abolish the VS-1-dependent eNOS phosphorylation (P(Ser1179)eNOS). These results suggest a novel signal transduction pathway for endogenous cationic and amphipathic peptides in endothelial cells: HSPGs interaction and caveolae endocytosis, coupled with a PI3K-dependent eNOS phosphorylation., ((c) 2010 Wiley-Liss, Inc.)
- Published
- 2010
- Full Text
- View/download PDF
37. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
- Author
-
Granata R, Trovato L, Gallo MP, Destefanis S, Settanni F, Scarlatti F, Brero A, Ramella R, Volante M, Isgaard J, Levi R, Papotti M, Alloatti G, and Ghigo E
- Subjects
- Adenylyl Cyclases metabolism, Adrenergic beta-Agonists pharmacology, Animals, Apoptosis drug effects, Calcium metabolism, Caspase 3 metabolism, Cell Line, Cell Survival, Cyclic AMP metabolism, Cyclic AMP-Dependent Protein Kinases metabolism, Cytoprotection, Growth Hormone-Releasing Hormone analogs & derivatives, Growth Hormone-Releasing Hormone pharmacology, Isoproterenol pharmacology, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Myocardial Contraction drug effects, Myocardial Reperfusion Injury metabolism, Myocardial Reperfusion Injury pathology, Myocytes, Cardiac drug effects, Myocytes, Cardiac enzymology, Myocytes, Cardiac pathology, Perfusion, Phosphatidylinositol 3-Kinases metabolism, RNA, Messenger metabolism, Rats, Receptors, Neuropeptide antagonists & inhibitors, Receptors, Neuropeptide metabolism, Receptors, Pituitary Hormone-Regulating Hormone antagonists & inhibitors, Receptors, Pituitary Hormone-Regulating Hormone metabolism, Recovery of Function, Time Factors, Ventricular Function, Left drug effects, Growth Hormone-Releasing Hormone metabolism, Myocardial Reperfusion Injury prevention & control, Myocytes, Cardiac metabolism, Signal Transduction drug effects, Signal Transduction genetics
- Abstract
Aims: The hypothalamic neuropeptide growth hormone-releasing hormone (GHRH) stimulates GH synthesis and release in the pituitary. GHRH also exerts proliferative effects in extrapituitary cells, whereas GHRH antagonists have been shown to suppress cancer cell proliferation. We investigated GHRH effects on cardiac myocyte cell survival and the underlying signalling mechanisms., Methods and Results: Reverse transcriptase-polymerase chain reaction analysis showed GHRH receptor (GHRH-R) mRNA in adult rat ventricular myocytes (ARVMs) and in rat heart H9c2 cells. In ARVMs, GHRH prevented cell death and caspase-3 activation induced by serum starvation and by the beta-adrenergic receptor agonist isoproterenol. The GHRH-R antagonist JV-1-36 abolished GHRH survival action under both experimental conditions. GHRH-induced cardiac cell protection required extracellular signal-regulated kinase (ERK)1/2 and phosphoinositide-3 kinase (PI3K)/Akt activation and adenylyl cyclase/cAMP/protein kinase A signalling. Isoproterenol strongly upregulated the mRNA and protein of the pro-apoptotic inducible cAMP early repressor, whereas GHRH completely blocked this effect. Similar to ARVMs, in H9c2 cardiac cells, GHRH inhibited serum starvation- and isoproterenol-induced cell death and apoptosis through the same signalling pathways. Finally, GHRH improved left ventricular recovery during reperfusion and reduced infarct size in Langendorff-perfused rat hearts, subjected to ischaemia-reperfusion (I/R) injury. These effects involved PI3K/Akt signalling and were inhibited by JV-1-36., Conclusion: Our findings suggest that GHRH promotes cardiac myocyte survival through multiple signalling mechanisms and protects against I/R injury in isolated rat heart, indicating a novel cardioprotective role of this hormone.
- Published
- 2009
- Full Text
- View/download PDF
38. Homing of annexin-labeled stem cells to apoptotic cells.
- Author
-
Gerasimou A, Ramella R, Brero A, Boero O, Sheiban I, Levi R, and Gallo MP
- Subjects
- Animals, Biotinylation, Cattle, Cell Line, Endothelial Cells metabolism, Ketones metabolism, Rats, Annexin A5 metabolism, Apoptosis, Cell Movement, Endothelial Cells cytology, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells metabolism, Staining and Labeling
- Abstract
Ischemic diseases are characterized by the presence of pro-apoptotic stimuli, which initiate a cascade of processes that lead to cell injury and death. Several molecules and events represent detectable indicators of the different stages of apoptosis. Among these indicators is phosphatidylserine (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by annexinV (ANXA5) conjugation. This is a widely used in vivo and in vitro assay marking the early stages of apoptosis. We report here on an original method that employs PS-ANXA5 conjugation to target stem cells to apoptotic cells. Mesenchymal stem cells (MSCs) from GFP-positive transgenic rats were biotinylated on membrane surfaces with sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-LC-biot) and then bound to avidin. The avidin-biotinylated MSCs were labeled with biotin conjugated ANXA5. Bovine aortic endothelial cells (BAE-1 cells) were exposed to UVC to induce caspasedependent apoptosis. Finally, we tested the ability of ANXA5-labeled MSCs to bind BAE-1 apoptotic cells: suspended ANXA5-labeled MSCs were seeded for 1 hour on a monolayer of UV-treated or control BAE-1 cells. After washing, the number of MSCs bound to BAE-1 cells was evaluated by confocal microscopy. Statistical analysis demonstrated a significant increase in the number of MSCs tagged to apoptotic BAE-1 cells. Therefore, stem cell ANXA5 tagging via biotin-avidin bridges could be a straightforward method of improving homing to apoptotic tissues.
- Published
- 2009
- Full Text
- View/download PDF
39. The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide.
- Author
-
Cerra MC, Gallo MP, Angelone T, Quintieri AM, Pulerà E, Filice E, Guérold B, Shooshtarizadeh P, Levi R, Ramella R, Brero A, Boero O, Metz-Boutigue MH, Tota B, and Alloatti G
- Subjects
- Animals, Aorta cytology, Aorta metabolism, Autocrine Communication drug effects, Autocrine Communication physiology, Calcium metabolism, Cardiotonic Agents pharmacology, Cattle, Chromogranin A pharmacology, Endothelial Cells cytology, Endothelin-1 pharmacology, Humans, Isoproterenol pharmacology, Male, Myocardial Contraction drug effects, Myocytes, Cardiac cytology, Papillary Muscles cytology, Paracrine Communication drug effects, Paracrine Communication physiology, Phosphatidylinositol 3-Kinases metabolism, Rats, Rats, Wistar, Structure-Activity Relationship, Vasodilation drug effects, Chromogranin A metabolism, Coronary Vessels metabolism, Endothelial Cells metabolism, Myocardial Contraction physiology, Myocytes, Cardiac metabolism, Nitric Oxide metabolism, Papillary Muscles metabolism, Vasodilation physiology
- Abstract
Chromogranin A (CGA), produced by human and rat myocardium, generates several biologically active peptides processed at specific proteolytic cleavage sites. A highly conserved cleavage N-terminal site is the bond 64-65 that reproduces the native rat CGA sequence (rCGA1-64), corresponding to human N-terminal CGA-derived vasostatin-1. rCGA1-64 cardiotropic activity has been explored in rat cardiac preparations. In Langendorff perfused rat heart, rCGA1-64 (from 33 nM) induced negative inotropism and lusitropism as well as coronary dilation, counteracting isoproterenol (Iso) - and endothelin-1 (ET-1) -induced positive inotropic effects and ET-1-dependent coronary constriction. rCGA1-64 also depressed basal and Iso-induced contractility on rat papillary muscles, without affecting calcium transients on isolated ventricular cells. Structure-function analysis using three modified peptides on both rat heart and papillary muscles revealed the disulfide bridge requirement for the cardiotropic action. A decline in Iso intrinsic activity in the presence of the peptides indicates a noncompetitive antagonistic action. Experiments on rat isolated cardiomyocytes and bovine aortic endothelial cells indicate that the negative inotropism observed in rat papillary muscle is probably due to an endothelial phosphatidylinositol 3-kinase-dependent nitric oxide release, rather than to a direct action on cardiomyocytes. Taken together, our data strongly suggest that in the rat heart the homologous rCGA1-64 fragment exerts an autocrine/paracrine modulation of myocardial and coronary performance acting as stabilizer against intense excitatory stimuli.
- Published
- 2008
- Full Text
- View/download PDF
40. Septic arthritis due to Haemophilus influenzae serotype a in the post-vaccination era in Brazil.
- Author
-
de Almeida AECC, Schroeder LFL, Caldeira NGS, da Silva NMM, Batista PR, Gallo MP, and de Filippis I
- Subjects
- Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Arthritis, Infectious epidemiology, Brazil epidemiology, Cefuroxime administration & dosage, Cefuroxime therapeutic use, Child, Preschool, Female, Haemophilus Infections prevention & control, Humans, Arthritis, Infectious microbiology, Arthritis, Infectious prevention & control, Haemophilus Infections epidemiology, Haemophilus Vaccines, Haemophilus influenzae
- Published
- 2008
- Full Text
- View/download PDF
41. Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium.
- Author
-
Gallo MP, Levi R, Ramella R, Brero A, Boero O, Tota B, and Alloatti G
- Subjects
- Adrenergic beta-Agonists pharmacology, Adrenergic beta-Antagonists pharmacology, Androstadienes pharmacology, Animals, Calcium Channels, L-Type metabolism, Cattle, Cells, Cultured, Chromogranin A pharmacology, Dose-Response Relationship, Drug, Endothelial Cells drug effects, Female, Heart Ventricles cytology, Heart Ventricles metabolism, Humans, In Vitro Techniques, Isoproterenol antagonists & inhibitors, Isoproterenol pharmacology, Muscle Strength, Myocytes, Cardiac drug effects, NG-Nitroarginine Methyl Ester pharmacology, Nitric Oxide Synthase antagonists & inhibitors, Nitric Oxide Synthase metabolism, Papillary Muscles drug effects, Peptide Fragments pharmacology, Phosphatidylinositol 3-Kinases metabolism, Phosphoinositide-3 Kinase Inhibitors, Protein Kinase Inhibitors pharmacology, Rats, Recombinant Proteins metabolism, Wortmannin, Adrenergic beta-Antagonists metabolism, Calcium Signaling drug effects, Chromogranin A metabolism, Endothelial Cells metabolism, Myocardial Contraction drug effects, Myocytes, Cardiac metabolism, Nitric Oxide metabolism, Papillary Muscles metabolism, Peptide Fragments metabolism
- Abstract
Vasostatins (VSs) are vasoactive peptides derived from chromogranin A (CgA), a protein contained in secretory granules of chromaffin and other cells. The negative inotropic effect and the reduction of isoproterenol (Iso)-dependent inotropism induced by VSs in the heart suggest that they have an antiadrenergic function. However, further investigation of the mechanisms of action of VSs is needed. The aim of the present study was to define the signaling pathways activated by VS-1 in mammalian ventricular myocardium and cultured endothelial cells that lead to the modulation of cardiac contractility. Ca(2+) and nitric oxide (NO) fluorometric confocal imaging was used to study the effects induced by recombinant human VS-1 [STA-CgA-(1-76)] on contractile force, L-type Ca(2+) current, and Ca(2+) transients under basal conditions and after beta-adrenergic stimulation in rat papillary muscles and ventricular cells and the effects on intracellular Ca(2+) concentration and NO production in cultured bovine aortic endothelial (BAE-1) cells. VS-1 had no effect on basal contractility of papillary muscle, but the effect of Iso stimulation was reduced by 27%. Removal of endocardial endothelium and inhibition of NO synthesis and phosphatidylinositol 3-kinase (PI3K) activity abolished the antiadrenergic effect of VS-1 on papillary muscle. In cardiomyocytes, 10 nM VS-1 was ineffective on basal and Iso (1 microM)-stimulated L-type Ca(2+) current and Ca(2+) transients. In BAE-1 cells, VS-1 induced a Ca(2+)-independent increase in NO production that was blocked by the PI3K inhibitor wortmannin. Our results suggest that the antiadrenergic effect of VS-1 is mainly due to a PI3K-dependent NO release by endothelial cells, rather than a direct action on cardiomyocytes.
- Published
- 2007
- Full Text
- View/download PDF
42. Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes.
- Author
-
Gallo MP, Ramella R, Alloatti G, Penna C, Pagliaro P, Marcantoni A, Bonafé F, Losano G, and Levi R
- Subjects
- Actinin metabolism, Animals, Animals, Genetically Modified, Boron Compounds, Calcium metabolism, Calcium Channel Blockers pharmacology, Calcium Channels physiology, Cell Differentiation, Cells, Cultured, Coculture Techniques, Connexin 43 metabolism, Dihydropyridines, Fluorescent Dyes, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Ion Channel Gating, Mesenchymal Stem Cells cytology, Myocytes, Cardiac cytology, Myosins metabolism, Nifedipine pharmacology, Rats, Sarcomeres metabolism, Mesenchymal Stem Cells physiology, Myocytes, Cardiac physiology
- Abstract
In order to assess, in a controlled in vitro model, the differentiation potential of adult bone marrow derived stem cells we have developed a coculture procedure using adult rat cardiomyocytes and mesenchymal stem cells (MSCs) from transgenic GFP positive rats. We investigated in the cocultured MSCs the time course of cellular processes that are difficult to monitor in in vivo experiments. Adult rat cardiomyocytes and adult rat MSCs were cocultured for up to 7 days and analyzed by confocal microscopy. Several markers were studied by immunofluorescence technique. The fluorescent ST-BODIPY-Dihydropyridine was used to label calcium channels in living cells. Intracellular calcium was monitored with the fluorescent probe X-Rhod-1. Immunofluorescence experiments showed the presence of connexin-43 between cardiomyocytes and MSCs and between MSCs, while no sarcomeric structures were observed at any time of the coculture. We looked at the expression of calcium channels and development of voltage-dependent calcium signaling in cocultured MSCs. MSCs showed a time-dependent increase of labeling of ST-BODIPY-Dihydropyridine, reaching a relatively strong level after 72 h of coculture. The treatment with a non-fluorescent DHP, Nifedipine, completely abolished ST-BODIPY labeling. We investigated whether depolarization could modulate intracellular calcium. Depolarization-induced calcium transients increased in MSCs in relation to the coculture time. We conclude that MSCs cocultured with adult cardiomyocytes present preliminary evidence of voltage-dependent calcium modulation uncoupled with the development of nascent or adult myofibrils, thus showing a limited lineage specification and a low plasticity to differentiate in a full cardiomyocyte-like phenotype., (2006 Wiley-Liss, Inc.)
- Published
- 2007
- Full Text
- View/download PDF
43. Phosphoinositide 3-kinasegamma (PI3Kgamma) controls L-type calcium current (ICa,L) through its positive modulation of type-3 phosphodiesterase (PDE3).
- Author
-
Marcantoni A, Levi RC, Gallo MP, Hirsch E, and Alloatti G
- Subjects
- Animals, Class Ib Phosphatidylinositol 3-Kinase, Colforsin pharmacology, Cyclic Nucleotide Phosphodiesterases, Type 3, Female, Heart Ventricles cytology, In Vitro Techniques, Isoenzymes genetics, Isoenzymes physiology, Male, Mice, Mice, Knockout, Muscle Cells drug effects, Myocardial Contraction drug effects, Receptors, Adrenergic, beta metabolism, Signal Transduction, 3',5'-Cyclic-AMP Phosphodiesterases metabolism, Calcium Channels, L-Type metabolism, Phosphatidylinositol 3-Kinases genetics, Phosphatidylinositol 3-Kinases physiology
- Abstract
The modulation of L-type calcium current (ICa,L) is mainly due to mediators acting through activation of G protein-coupled receptors (GPCR) and different protein kinases; among them, phosphoinositide 3-kinasegamma (PI3Kgamma) has been recently discovered to play an important role in the regulation of cardiac contractility and beta-adrenergic signal transduction. Recent reports have demonstrated that, in the heart, different subtypes of beta-adrenergic receptors are coupled to both Gi and/or Gs proteins. While beta1-adrenergic receptors (beta1-AR) couple only to Gs and evoke a strong ICa,L, beta2-adrenergic receptors (beta2-AR) can activate both Gs and Gi proteins and trigger only a limited ICa,L. Here we demonstrate that (i) PI3Kgamma-/- ventricular myocytes are characterized by an higher basal ICa,L density, even if the responsiveness of adenylyl cyclase to Forskolin is comparable to that observed in PI3Kgamma+/+ cardiomyocytes; (ii) both in basal conditions and after beta-AR stimulation, the activity of phosphodiesterase (PDE) type 3 depends on PI3Kgamma; (iii) in PI3Kgamma-/- cardiac myocytes, specific stimulation of beta2-AR is followed by a increase in ICa,L stronger than in wild-type controls. Taken together, our results suggest that the higher values of ICa,L observed both in basal conditions and after beta-AR stimulation in PI3Kgamma-/- ventricular myocytes are mainly due to a positive modulation of PDE3 activity exerted by PI3Kgamma. As observed in PI3Kgamma-/- neonatal cardiomyocytes, cells lacking PI3Kgamma are more sensitive to stimulation of beta2-adrenergic receptors., (Copyright (c) 2005 Wiley-Liss, Inc.)
- Published
- 2006
- Full Text
- View/download PDF
44. Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level.
- Author
-
Alloatti G, Marcantoni A, Levi R, Gallo MP, Del Sorbo L, Patrucco E, Barberis L, Malan D, Azzolino O, Wymann M, Hirsch E, and Montrucchio G
- Subjects
- Animals, Carbachol pharmacology, Class Ib Phosphatidylinositol 3-Kinase, Cyclic AMP analysis, Down-Regulation, G Protein-Coupled Inwardly-Rectifying Potassium Channels, GTP-Binding Protein alpha Subunits, Gi-Go metabolism, Heart Rate drug effects, Heart Rate genetics, Heart Rate physiology, In Vitro Techniques, Isoenzymes genetics, Isoproterenol pharmacology, Mice, Mice, Mutant Strains, Myocardial Contraction genetics, Myocardium chemistry, Phosphatidylinositol 3-Kinases genetics, Potassium Channels, Inwardly Rectifying physiology, Receptors, Adrenergic, beta drug effects, Receptors, Adrenergic, beta physiology, Receptors, Muscarinic drug effects, Receptors, Muscarinic physiology, Adrenergic beta-Agonists pharmacology, Cyclic AMP metabolism, Isoenzymes physiology, Muscarinic Antagonists pharmacology, Myocardial Contraction physiology, Myocardium enzymology, Phosphatidylinositol 3-Kinases physiology
- Abstract
Cardiac beta-adrenergic and the muscarinic receptors control contractility and heart rate by triggering multiple signaling events involving downstream targets like the phosphoinositide 3-kinase gamma (PI3Kgamma). We thus investigated whether the lack of PI3Kgamma could play a role in the autonomic regulation of the mouse heart. Contractility and ICaL of mutant cardiac preparations appeared increased in basal conditions and after beta-adrenergic stimulation. However, basal and beta-adrenergic stimulated heart rate were normal. Conversely, muscarinic inhibition of heart rate was reduced without alteration of the Gbetagamma-dependent stimulation of IK,ACh current. In addition, muscarinic-mediated anti-adrenergic effect on papillary muscle contractility and ICaL was significantly depressed. Consistently, cAMP level of PI3Kgamma-null ventricles was always higher than wild-type controls. Thus, PI3Kgamma controls the cardiac function by reducing cAMP concentration independently of Gi-mediated signaling.
- Published
- 2005
- Full Text
- View/download PDF
45. Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in guinea pig myocytes.
- Author
-
Malan D, Levi RC, Alloatti G, Marcantoni A, Bedendi I, and Gallo MP
- Subjects
- Animals, Calcium metabolism, Calcium Channels drug effects, Calcium Signaling drug effects, Calcium Signaling physiology, Guinea Pigs, Heart Ventricles drug effects, Metalloporphyrins pharmacology, Molsidomine pharmacology, Myocytes, Cardiac cytology, Myocytes, Cardiac drug effects, Nitric Oxide metabolism, Nitric Oxide Donors pharmacology, Pyrogallol pharmacology, Superoxide Dismutase pharmacology, Up-Regulation drug effects, Up-Regulation physiology, Calcium Channels physiology, Cyclic AMP metabolism, Cyclic GMP metabolism, Heart Ventricles metabolism, Molsidomine analogs & derivatives, Myocytes, Cardiac metabolism, Peroxynitrous Acid metabolism
- Abstract
We investigated the potential involvement of peroxynitrite (ONOO(-)) in the modulation of calcium current (I(Ca)) in guinea pig ventricular myocytes with the whole-cell patch clamp technique and with cyclic AMP (cAMP) measurements. Because of the short half-life of ONOO(-) at physiological pH, we induced an increase in its intracellular levels by using donors of the precursors, nitric oxide (NO) and superoxide anion (O(2) (-)). High concentrations of NO donors, SpermineNONOate (sp/NO, 300 microM) or SNAP (300 microM) increased basal I(Ca) (50.3 +/- 4.6%, n = 7 and 46.2 +/- 5.0%, n = 13). The superoxide anion donor Pyrogallol (100 microM) also stimulated basal I(Ca) (44.6 +/- 2.8%, n = 11). At lower concentration sp/NO (10 nM) and Pyrogallol (1 microM), although separately ineffective on I(Ca), enhanced the current if applied together (33.5 +/- 0.7%, n = 7). The simultaneous donor of O(2) (-) and NO, SIN-1 (500 microM), also stimulated basal I(Ca) (22.8 +/- 2.1%, n = 13). In the presence of saturating cyclic GMP (cGMP, 50 microM) in the patch pipette or of extracellular dibutyryl cGMP (dbcGMP, 100 microM), I(Ca) was still increased by SIN-1 (32.0 +/- 6.1%, n = 4 and 30.0 +/- 5.4%, n = 8). Both Manganese(III)tetrakis(4-benzoic acid) porphyrin chloride (MnTBAP, 100 microM) a ONOO(-) scavenger, and superoxide dismutase (SOD) (150 U/ml) reversed the stimulatory effect of SIN-1 on I(Ca) (respectively -0.6 +/- 4.1%, n = 4 and 3.6 +/- 4.3%, n = 4). Intracellular cAMP level was unaltered by SIN-1, while it was enhanced by blocking the NO-cGMP pathway with the NO synthase inhibitor L-NMMA. These results suggest that peroxynitrite donors increase cardiac calcium current without the involvement of cAMP and cGMP.
- Published
- 2003
- Full Text
- View/download PDF
46. Microtubules mobility affects the modulation of L-type I(Ca) by muscarinic and beta-adrenergic agonists in guinea-pig cardiac myocytes.
- Author
-
Malan D, Gallo MP, Bedendi I, Biasin C, Levi RC, and Alloatti G
- Subjects
- Adenosine pharmacology, Animals, Atrial Function, Carbachol pharmacology, Cells, Cultured, Colchicine pharmacology, Cyclic AMP metabolism, Electric Conductivity, Female, Guinea Pigs, Heart Atria drug effects, Immunoenzyme Techniques, Isoproterenol pharmacology, Male, Microtubules drug effects, Movement, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Paclitaxel pharmacology, Purinergic Agonists, Adrenergic beta-Agonists pharmacology, Calcium Channels, L-Type metabolism, Microtubules physiology, Muscarinic Agonists pharmacology, Myocytes, Cardiac physiology
- Abstract
To investigate the interaction of cytoskeleton with the receptor modulation of ionic currents, we studied the effect of muscarinic and beta-adrenergic stimulation in adult guinea-pig ventricular cardiac myocytes treated with paclitaxel and colchicine, two drugs that respectively stabilize or destabilize microtubules. We observed that the stabilization of microtubules with paclitaxel (1 microM for 1-4 h) did not markedly affect either the kinetics of I(Ca), or the stimulatory effect of isoproterenol (Iso, 1 microM); however paclitaxel significantly blunted the response to carbachol (CCh, 1 microM). In agreement with the electrophysiological measurements, Iso induced a similar enhancement of intracellular cAMP levels in both control and paclitaxel-treated cells, while the response to CCh 1 microM was significantly reduced in paclitaxel-treated cells. The reduction of muscarinic response induced by paclitaxel was also evident in atrial cells, in which the stimulation of I(KACh) by CCh 1 microM was reduced to about 10%. Compared to the muscarinic response, paclitaxel did not have significant effect on the purinergic (adenosine 1-10 microM) modulation of I(Ca). In contrast to paclitaxel, in colchicine-treated cells, I(Ca) was not enhanced by beta-adrenergic stimulation, but instead reduced by CCh, even in the absence of previous stimulation. In conclusion, our data suggest that microtubule stabilization significantly affects the muscarinic modulation of I(Ca), by interacting with the receptor or the G-protein rather than on the intracellular signaling cascade.
- Published
- 2003
- Full Text
- View/download PDF
47. Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle.
- Author
-
Bedendi I, Gallo MP, Malan D, Levi RC, and Alloatti G
- Subjects
- Animals, Dose-Response Relationship, Drug, Myocardial Contraction drug effects, Nitric Oxide physiology, Rats, Time Factors, Endothelium, Vascular physiology, Myocardial Contraction physiology, Oligopeptides pharmacology, Ventricular Function
- Abstract
The synthetic growth hormone (GH) secretagogue hexarelin has important cardiac effects, that include a reduction of dysfunction in ischemic-reperfused hearts from GH-deficient rats after a chronic treatment and an increase of ejection fraction in acutely treated men. To investigate the mechanisms of its cardiac activity, we studied the effects of hexarelin (1-10 microM) on contractility of rat papillary muscles. We observed, in hexarelin treated papillary muscles, an improved recovery of contractility after anoxia. Hexarelin induced time- and frequency-dependent inotropic effects on papillary muscle. These effects were a transient increase in contractile force, abolished by propranolol (0.2 microM), followed by a reduction at low (60-240/min), but not at high (400-600/min) beating frequencies. The typical negative force-frequency relationship present in rat papillary muscles was therefore modified, and a minor increase in diastolic tension occurred after a sudden increase in stimulus frequency. Blockade of NO synthesis with 1 mM L-NAME, partially altered the response to hexarelin. MK-677 (1 microM), a non peptidyl GH secretagogue, reduced contractility, but did not alter the force-frequency relationship. The remaining effects of hexarelin were absent in papillary muscles pre-treated with indomethacin (1 microM), or after removal of endocardial endothelium with 0.5% triton X-100. The release of the prostacyclin metabolite 6-keto-PGF1alpha was increased during reoxygenation after a period of anoxia in hexarelin treated papillary muscles. Hexarelin had no significant effect on calcium transients and on I(Ca) measured in isolated ventricular cells. These findings suggest that the effects of hexarelin are mainly due to endothelium-released PGI2.
- Published
- 2001
- Full Text
- View/download PDF
48. Regulation of cardiac calcium current by NO and cGMP-modulating agents.
- Author
-
Gallo MP, Malan D, Bedendi I, Biasin C, Alloatti G, and Levi RC
- Subjects
- Adenine pharmacology, Animals, Arginine pharmacology, Biological Transport drug effects, Biological Transport physiology, Carbachol pharmacology, Cholinergic Agonists pharmacology, Cyclic N-Oxides pharmacology, Enzyme Inhibitors pharmacology, Exonucleases antagonists & inhibitors, Free Radical Scavengers pharmacology, Guinea Pigs, Imidazoles pharmacology, In Vitro Techniques, Orchiectomy, Oxadiazoles pharmacology, Quinoxalines pharmacology, Receptors, Muscarinic metabolism, omega-N-Methylarginine pharmacology, Adenine analogs & derivatives, Calcium Channels, L-Type metabolism, Cyclic GMP metabolism, Myocardium metabolism, Nitric Oxide metabolism
- Abstract
Several effects of nitric oxide (NO) on the control of L-type calcium current (ICa) and of calcium handling in cardiomyocytes have been described. Cardiomyocytes have been shown to express in different conditions all types of nitric oxide synthases (NOS), but the role of NO in the regulation of calcium current remains controversial. Previously, we have shown in guinea pig ventricular cells a stimulatory effect of NOS inhibitors on ICa. Here we investigate the intracellular mechanisms involved in the putative inhibitory role of NO on basal ICa in ventricular cells. The stimulatory effect of the NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) (1 mM) was present also in calcium transient measurements, but only after a preincubation with L-arginine (L-arg, 0.1 mM). The nitric oxide scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO, 0.5 mM) increased peak ICa in a similar manner to NOS inhibitors in whole-cell voltage-clamp experiments. Also ODQ (1H-[1,2,4]oxidiazolo[4,3-a]quinoxaline-1-one, 0.1 mM), a specific inhibitor of a target of NO, the soluble guanylate cyclase, was able to stimulate ICa. The block of type II phosphodiesterase (cGMP-activated) by EHNA (erythro-9-[2-hydroxy-3-nonylladenine, 30 microM) exerted a similar effect on ICa as PTIO and ODQ. Carbachol (CCh, 1 microM) was able to revert the stimulatory effect on ICa observed with PTIO, ODQ, and EHNA. We propose that the increase of basal ICa in guinea pig cardiomyocytes previously observed with L-NMMA depends on the removal of a tonic NO inhibition. This increase of ICa is mimicked by blocking at different steps the cGMP-cascade activated by NO, suggesting a NO-guanylate cyclase mechanism in the basal control of ventricular calcium current.
- Published
- 2001
- Full Text
- View/download PDF
49. Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors.
- Author
-
Gallo MP, Ghigo D, Bosia A, Alloatti G, Costamagna C, Penna C, and Levi RC
- Subjects
- Animals, Blotting, Western, Carbachol pharmacology, Citrulline metabolism, Electrophysiology, Female, Guanosine Diphosphate analogs & derivatives, Guanosine Diphosphate pharmacology, Guinea Pigs, Heart drug effects, Heart Ventricles drug effects, Heart Ventricles metabolism, In Vitro Techniques, Male, Membrane Potentials drug effects, Membrane Potentials physiology, Muscarinic Antagonists pharmacology, Nitric Oxide biosynthesis, Nitroarginine antagonists & inhibitors, Nitroarginine pharmacology, Patch-Clamp Techniques, Thionucleotides pharmacology, omega-N-Methylarginine antagonists & inhibitors, omega-N-Methylarginine pharmacology, Calcium Channels drug effects, Enzyme Inhibitors pharmacology, Myocardium metabolism, Nitric Oxide Synthase antagonists & inhibitors
- Abstract
1. Electrophysiological (whole-cell clamp) techniques were used to study the effect of NO synthase (NOS) inhibitors on guinea-pig ventricular calcium current (ICa), and biochemical measurements (Western blot and citrulline synthesis) were made to investigate the possible mechanisms of action. 2. The two NOS inhibitors, NG-monomethyl-L-arginine (L-NMMA, 1 mM) and NG-nitro-L-arginine (L-NNA, 1 mM), induced a rapid increase in ICa when applied to the external solution. D-NMMA (1 mM), the stereoisomer of L-NMMA, which has no effect on NOS, did not enhance ICa. 3. Western blot experiments gave no indication of the presence of inducible NOS protein (iNOS) in our cell preparation, neither immediately after dissociation nor after more than 24 h. Statistically, there was no significant difference between electrophysiological experiments performed on freshly dissociated cells and experiments performed the next day. Moreover cells prepared and kept in the presence of dexamethasone (3 microM), to inhibit the expression of iNOS, gave the same response to L-NMMA as control cells. 4. The stimulatory effect of L-NMMA (1 mM) on basal ICa was reversed by competition with higher doses (5 mM) of externally applied L-arginine, the natural substrate of NOS. The effect of L-NMMA was also eliminated by L-arginine in the patch pipette solution. 5. Intracellular perfusion with GDP beta S (0.5 mM), which stabilizes the G-proteins in the inactive state, did not affect the L-NMMA-induced stimulation of ICa. 6. Carbachol (1 microM) reduced the ICa previously stimulated by L-NMMA, and intracellular cGMP (10 microM) prevented L-NMMA enhancement. 7. Simultaneous treatment with L-NMMA and isoprenaline (1 microM) induced a non-cumulative enhancement of ICa that could not be reversed by carbachol (1 microM). 8. NO synthesis, measured by the formation of [3H]citrulline from L-[3H]arginine during a 15 min incubation, showed a relatively high basal NO production, which was inhibited by L-NMMA but not affected by carbachol. 9. These results suggest that inhibitors of NOS are able to modulate the basal ventricular ICa in the absence of a receptor-mediated pathway, and that NO might be required for the muscarinic reduction of ICa under isoprenaline stimulation, even if NO production is not directly controlled by the muscarinic pathway.
- Published
- 1998
- Full Text
- View/download PDF
50. Effects of yew alkaloids and related compounds on guinea-pig isolated perfused heart and papillary muscle.
- Author
-
Alloatti G, Penna C, Levi RC, Gallo MP, Appendino G, and Fenoglio I
- Subjects
- Animals, Antineoplastic Agents, Phytogenic pharmacology, Coronary Circulation drug effects, Depression, Chemical, Guinea Pigs, Heart physiology, In Vitro Techniques, Myocardial Contraction drug effects, Papillary Muscles physiology, Perfusion, Alkaloids pharmacology, Heart drug effects, Papillary Muscles drug effects, Plant Extracts pharmacology, Plants, Medicinal chemistry, Trees chemistry
- Abstract
The mechanical and electrical effects of selected yew alkaloids were studied on two different cardiac preparations: the isolated coronary perfused heart and the isolated papillary muscle of the guinea-pig. In the isolated heart, the Winterstein acid type alkaloids 1, 2 and 3 induced electrical and mechanical effects similar to those reported after yew intoxication (negative inotropic effect, block of atrio-ventricular conduction), but the coronary flow was unchanged. Taxine B (1), the most potent compound of this group, reduced cardiac contractility and the maximum rate of depolarisation of the action potential in the isolated papillary muscle, acting as a class I antiarrhythmic drug. In the isolated heart, the cinnamates 4 and 5, corresponding to the degradation products of 1 and 3, exerted arrhythmogenic effect due to a reduction of coronary flow. No alterations in electrical and contractile activities were in fact recorded after perfusion of the isolated papillary muscle with 4. Taxine A (6) and the taxane alcohol 7, corresponding to the terpenoid core of 3 had no significant cardiac effect. Our results suggest that the poisonous properties of the yew tree are probably due to the combined activity of alkaloids of the Winterstein acid type and their corresponding cinnamtes, which can reduce both the excitability and the coronary flow of the heart.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.